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LIST OF ABBREVIATIONS 
APC Anaphase-promoting complex, ubiquitin ligase complex at 
the end of mitosis 
Cak Cdk-activating kinase 
Cdc Cell division cycle, Cdc2 is S. pombe cyclin-dependent 
kinase, Cdc28 is S. cerevisiae cyclin-dependent kinase, the 
same as Cdk1, and Cdc4 is a substrate recognition subunit of 
the ubiquitin ligase E3 complex 
Cdk Cyclin-dependent kinase 
CIP/KIP Cdk-interacting protein/kinase inhibitory protein, a mamma-
lian Cki family that contains the p21cip1, P27kip1, and p57kip2 
proteins 
Cip1 Cyclin-dependent kinase inhibitor 1, Cki in S. cerevisiae 
Ck2 Casein kinase 2 
Cki Cyclin-dependent kinase inhibitor 
Cks Cdc28 kinase subunit, S. cerevisiae Cks1 is a phospho-
adaptor subunit of Cdk 
Clb Cyclin B, cyclins of S and M phase in S. cerevisiae 
Cln G1-phase type (G1-type) cyclin in S. cerevisiae 
CTD C-terminal domain 
D1 Domain 1 in p27 KID 
D2 Domain 2 in p27 KID 
Far1 Pheromone-activated response 1, Cki in S. cerevisiae 
HP Hydrophobic patch, the substrate docking site of a certain 
subset of cyclins 
IDP Intrinsically disordered protein 
INK4 Inhibitor of Cdk4, a mammalian Cki family protein that 
contains the p16INK4a, p15INK4b, p18INK4c and p19INK4d proteins 
KID Kinase inhibitory domain, a region in Cki that is responsible 
for Cdk inhibition 
MAPK Mitogen-activated protein kinase 
MRAIL helix Helix in the subset of cyclins; the acronym is derived from 
the amino acid consensus sequence 
NTD N-terminal domain 
NMR Nuclear magnet resonance 
Pho Phosphate metabolism-related, Pho85 is a cyclin-dependent 
kinase in S. cerevisiae 
pRb Retinoblastoma protein, a mammalian transcription repressor  
PSTAIRE helix Helix in Cdks, a structural element at the cyclin-Cdk contact 
surface 
SBF/MBF Protein complexes regulating transcription in S. cerevisiae 
during G1, a metazoan E2F homolog 
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SCF Skp, Cullin, F-box-containing complex, E3 ubiquitin ligase 
in S-cerevisiae 
Sic1 Substrate inhibitor of cyclin-dependent protein kinase, 
S. cerevisiae Cki 
Skp1 S-phase kinase-associated protein 1, adaptor protein for E3 
ubiquitin ligase 
Whi5 Whiskey 5, transcription repressor protein associated with 




The cell division cycle is a process where cells duplicate their chromosomes and 
segregate them by forming two new daughter cells. To sustain the subsequent 
life of daughter cells, an errorless copy of the genome as well as adequate 
resources of other cellular contents must be synthesized and passed on upon 
division. 
In all eukaryotic organisms, the cell cycle can be divided into three main 
phases: growth phase, S phase and mitosis. The growth phase and S phase 
together are also called interphase. All microscopically well distinguishable 
events, such as centrosome duplication, chromosomal condensation, nuclear 
envelope breakdown, spindle formation, chromosome separation and finally 
cytokinesis, were first described during the 19th century. 
Cell biology reached a truly molecular level after the 1950s with the 
discovery of the DNA structure and its regular duplication in the cell division 
cycle; the interphase was additionally divided into distinct G1 and S phases, and 
the pause between DNA doubling and the first mitotic event was termed the G2 
phase, separating the cell cycle into four timely distinct phases (Howard & Pelc, 
1951; Watson & Crick, 1953; Meselson, 1958) (Fig. 1). Further studies revealed 
that the transitions between the phases are irreversible and unidirectional (Rao 
& Johnson, 1970). Additionally, in yeast and metazoan cells, G1 phase contains 
a certain moment where further progression toward S phase becomes 
independent of external (mating or mitogenic) signals, which was coined as the 
START-point in yeast and the restriction point in metazoans (Hartwell, et al., 
1970; Pardee, 1974). Therefore, G1 phase has an early stage and a late G1 stage 
when the commitment decision to enter the cell division cycle is made (Fig. 1). 
All the main events of the cell cycle are periodically intercepted at certain 
points called cell-cycle checkpoints. These points are placed between the G1/S 
and G2/M phase and to the end of mitosis and from which further progression is 
impossible if progression through the previous phase is delayed or impaired 
(Weinert & Hartwell, 1988; Hartwell & Weinert, 1989; Hoyt, et al., 1991; Li & 
Murray, 1991 ) (Fig. 1). 
The molecular guardians and assistants of this elaborate and precise 
mechanism have been at the main stage of molecular and cellular biology ever 
since these discoveries, as understanding the regulation of the cell division 




2. LITERATURE REVIEW 
2.1. The coordination of the cell cycle 
To ensure sufficient preparedness for the cell division cycle and to carry 
through its main events unimpaired, the decision to enter the cell division cycle 
is a tightly controlled process (Morgan, 2007). At the checkpoints, the cells 
check whether previous cell cycle phases have produced sufficient results to 
trigger irreversible transition to the next cell cycle phase (Morgan, 2007). The 
complexity of environmental and cellular conditions and the irreversible nature 
of complex cell division mechanisms place considerable stress on the decision-
making process and necessitate high degrees of robustness (Zhu & Yanlan, 
2015). 
In eukaryotic organisms, cell cycle coordination is achieved via controlling 
enzyme activity, protein stability, and localization (Morgan, 2007). The master 
regulators of the cell cycle are cyclin-dependent kinases (Cdks) (Hartwell, et al., 
1970; Hartwell, et al., 1974; Lohka, et al., 1988), their interaction partner cyclins 
(Evans, et al., 1983; Swenson, et al., 1986; Murray & Kirschner, 1989) and cell 
cycle-dependent phosphatases (Nurse, 1975; Fantes, 1979; Gould & Nurse, 
1991). 
The general course of the cell cycle is controlled by an overall increase in 
Cdk activity, leading to concurrent increases in protein phosphorylation (Bloom 
& Cross, 2007) (Fig. 1). The number of substrates that are phosphorylated 
reaches its maximum at the end of mitosis during the metaphase-to-anaphase 
transition, after which Cdk activity is downregulated and the phosphatases 
dephosphorylate Cdk substrates (Fantes, 1979; Russell & Nurse, 1986; Gould & 
Nurse, 1991; Swaffer, et al., 2016) (Fig. 1). Cdks govern the beginning and the 
transition through the cell cycle, while finishing off the cell cycle is triggered by 
ubiquitin ligase APC, ubiquitin-directed proteolysis and phosphatase that 




Figure 1. A generalized diagram of S. cerevisiae cell cycle control. Cell division 
progress through four phases (inner circle): G1, S, G2 and M. Each cell cycle phase is 
separated by irreversible transitions (arrow shapes) governed by cell cycle checkpoints 
(START, G1/S, G2/M and SA – spindle assembly). Each cell cycle phase is governed 
by different cyclin subunits activating Cdk1. The temporal order of the cyclins changes 
the specificity and total activity of Cdk1 (colored areas). The total Cdk1 kinase activity 
is rising throughout the cell cycle (dotted line, red). During the G1-phase the Cb5,6-Cdk1 
activity is kept inhibited by Sic1 (yellow area). After G1/S transition Sic1 is degraded 
and active Clb5,6-Cdk1 released (light red area). 
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2.2. The Cdk holoenzyme in the cell cycle 
The components of the eukaryotic cell division control system are largely 
conserved, from yeast to humans (Morgan, 2007). The central actuators of the 
cell division process are cyclins, proteins with temporal expression waves that 
generate oscillatory control over the activity of Cdks (Morgan, 2007) (Fig. 1). 
Since the initial discovery of cyclin proteins in sea urchin eggs (Evans, et al., 
1983) the behavior of these proteins, including their expression, localization, 
and degradation, is firmly regimented in a cell cycle-dependent manner 
(Morgan, 2007). The catalytic partner of cyclins, cyclin-dependent kinase 
(Cdk), initially discovered in yeast (Nurse, 1975; Hartwell, et al., 1974) is an 
approximately 34 kDa protein that possesses phosphorylation activity only upon 
binding with its heteromeric cyclin partner (Lohka, et al., 1988; Moreno, et al., 
1989). The third essential heteromeric subunit, a small protein (9–18 kDa) 
called Cks (Cdc28 kinase subunit), is a highly conserved binding partner to Cdk 
(Pines, 1996) (Fig. 3). Initially discovered in fission yeast (Hayles, et al., 1986), 
Cks1 is essential for cell cycle progression (Pines, 1996). Required for the 
assembly of some cyclin-Cdk heteromeric complexes and exhibiting a phosphate-
binding pocket, Cks1 contributes to the recognition of phosphorylated substrates 
by the cyclin-Cdk complex (Bourne, et al., 1996; Harper, 2001; Balog, et al., 
2011).  
Nine Cdk interacting cyclins that have temporal cell cycle-related roles are 
expressed in yeast (Malumbres, 2014). In humans, at least 29 proteins are 
members of the cyclin protein family, and 15 of the proteins are interacting 
partners for the Cdks, as established by sequence similarity (Malumbres, 2014). 
Centrally important cyclins can be divided into two subsets: G1-and S/M-phase 
cyclins. The yeast G1 family contains cyclins Cln1-3, and the S/M-phase 
cyclins are Clb1-4. The corresponding mammalian D, E (G1), A, and B cyclin 
(S) families are partly interchangeable with the yeast cyclins (Morgan, 1997) 
(Table 1).  
For cell cycle regulation in yeast, there is only one essential Cdk, a proto-
typical Cdk1 alternatively known as Cdc28 (Morgan, 2007). Another cell cycle 
regulator, Pho85, is an auxiliary nutrient sensitive Cdk (Malumbres, 2014). 
Four additional yeast Cdks, Kin28, Srb10, Bur1 and Ctk1, play a role in tran-
scriptional regulation and are involved in the cell cycle only through secondary 
processes (Malumbres, 2014). 
Although there are 20 Cdk genes in human cells, only Cdk1-6 are directly 
involved in cell cycle regulation, and Cdk1 is the only essential and sufficient 
Cdk for in vitro cell culture and for early embryo development (Santamaria, et 
al., 2007; Malumbres, 2014). Other mammalian Cdk-encoding genes either play 
auxiliary cell cycle roles or are not involved in cell cycle regulation (Morgan, 
2007; Malumbres & Barbacid, 2005). The central human Cdk genes can be 
replaced by the baker’s yeast Cdk1 gene or the fission yeast Cdc2 gene, and the 
cell-cycle regains complete regulation (Lee & Nurse, 1987; Wittenberg & Reed, 
1989; Malumbres & Barbacid, 2005). 
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Cdk activity differentiates over time and space of the cell as it is combined 
with different cyclins to form an active holoenzyme complex (Fig. 1, Table 1). 
Saccharomyces cerevisiae is one of the most important prototypical model for 
understanding cell cycle regulation. The transition from early to late G1 in yeast 
is dependent on growth-dependent accumulation of Cln3-Cdk1 activity 
(Polymenis & Schmidt, 1997). The accumulation of the early cyclin-Cdk 
complex results in phosphorylation of Whi5, the transcription repressor 
(mammalian pRb homolog) that represses SBF-/MBF-dependent gene expres-
sion (Costanzo, et al., 2004; de Bruin, et al., 2004). The phosphorylation of 
Whi5 results in the derepression of its associated promoters, resulting in 
transcription of late G1- and S-phase-related genes (Costanzo, et al., 2004). At 
this point, coined as a restriction point or START, the accumulation of G1-
specific Cln1,2-Cdk1 begins (Wittenberg, et al., 1990; Tyers, et al., 1993; Stuart 
& Wittenberg, 1995; Doncic, et al., 2011) (Fig. 1). In addition, S-phase-specific 
Clb5,6-Cdk1 starts to accumulate (Nasmyth & Dirick, 1991; Schwob & 
Nasmyth, 1993) but unlike Cln1-3-Cdk1, Clb5 and 6-Cdk1 are immediately 
inhibited by the yeast Cki (cyclin-dependent kinase inhibitor) Sic1 
(Mendenhall, 1993; Schwob & Nasmyth, 1993) (Table 1). S phase is initiated 
by phosphorylation-dependent abrupt degradation of Sic1 and the subsequent 
release of Clb5,6-Cdk1 activity (Nughoro & Mendenhall, 1994; Schwob, et al., 
1994; Donovan, et al., 1994). The progression through S phase is assisted by 
Clb3,4-Cdk1, and the following mitotic events are coordinated by the activation 
of Clb1,2-Cdk1 accumulated during S phase (Tachibana, et al., 1987; 
Richardson, et al., 1992; Kuczera, et al., 2010) (Table 1). 
 
Table 1. Central cell cycle regulating Cdks, associated cyclins and Ckis. S. cerevisiae 
and metazoan core drivers of early G1 (or G0-to-G1 transition), late G1 and early 
S phase, S phase and G2/M phase. Adapted from (Malumbres & Barbacid, 2005; 
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Although metazoan Cdk protein families are diverse, the general involvement 
of different cyclin-Cdk complexes in basic cell cycle regulation follows a 
prototypical model that was first described in yeast (Morgan, 2007) (Table 1). 
The G0 or early G1 progression to the restriction point is driven by mitogenic 
signals that induce the production and gradual activation of early cyclin  
D-Cdk4,6 complexes (Ortega, et al., 2002; Kato, et al., 1994). The activation of 
cyclin D-Cdk4,6 includes mitogen-dependent modulation of Cdk inhibitory 
proteins (Ckis) from INK4 and CIP/KIP families to release early kinase activity 
(Sherr & Roberts, 1999) (Table 1). The activated cyclin D-Cdk4,6 phosphory-
lates a transcription repressor from the retinoblastoma protein (pRb) family, 
which in turn relieves the E2F-dependent transcriptional program (Kato, et al., 
1993; Connell-Crowley, et al., 1997). Subsequent transcription of late G1- and 
S-phase genes results in the production and accumulation of cyclin E-Cdk2, 
cyclin A-Cdk2 and cyclin A-Cdk1 complexes (Ortega, et al., 2002; Sherr & 
Roberts, 1999) (Table 1). During its accumulation in middle G1, cyclin E,A-
Cdk2 kinase activity is tightly inhibited by binding a Cki protein belonging to 
the CIP/KIP family and becomes gradually active during late G1 (Galea, et al., 
2008; Galea, et al., 2008). The phosphorylation-dependent degradation of the 
CIP/KIP family inhibitors results in the abrupt release of cyclin E,A-Cdk2 
activity that initiates DNA replication and S phase (Jackson, et al., 1995; 
Ohtsubo, et al., 1995; Woo & Poon, 2003). After completing S phase, cells 
progress through mitosis by using the activity of the accumulated cyclin B-
Cdk1 (Gavet & Pines, 2010; Hara, et al., 2012; Lindqvist, et al., 2009). 
In both yeast and humans, the first cyclin accumulates over time under 
conditions of cell growth and persistent mitogenic signals (Ortega, et al., 2002; 
Santamaria & Ortega, 2006; McInerny, et al., 1997) (Fig. 1). This accumulation 
finally triggers the removal of transcriptional repression of hundreds of genes 
by which the other components of the cyclic oscillator of the cell cycle control 
system are produced. The generation of cyclic activity waves or the oscillation 
of different cyclin-Cdk activities following the START event of the cell cycle 
requires positive and negative feedback loops generated by rapid activation or 
inhibitory activities controlling cyclin-Cdk activity. 
 
 
2.3. Structural properties of Cdk holoenzyme activation 
Cyclin-dependent kinases are minimalistic protein kinases that share common 
structures with most serine or threonine protein kinases (Morgan, 1997). Mam-
malian Cdk1-6 share 41–65% of their sequence identity with prototypical yeast 
Cdk1, while human Cdk2 and Cdk3 share over 62% of their identity. The 
extensive crystallographic studies of mammalian Cdk2 (De Bondt, et al., 1993; 
Russo, et al., 1996; Jeffrey, et al., 1995; Davies, et al., 2001; Honda, et al., 
2005; Bourne, et al., 1996; Brown, et al., 1999), Cdk1 (Brown, et al., 2015), 
Cdk4 (Day, et al., 2009; Takaki, et al., 2009) or Cdk6 (Brotherton, et al., 1998) 
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complexed with cyclin or Cks subunits provide detailed information about 
common structural features that are most likely conserved in yeast Cdk1. 
The human Cdk2 protein kinase subunit is a bean-shaped molecule con-
taining two lobes, the N-terminal and C-terminal, and a cleft between the lobes 
(De Bondt, et al., 1993) (Fig. 2). The N-terminal lobe is smaller and contains a 
beta sheet and PSTAIRE helix (De Bondt, et al., 1993). The C-terminal lobe is 
larger and contains a number of helixes (De Bondt, et al., 1993). The cleft 
between the lobes contains residues to accommodate ATP and a substrate and to 
catalyze phosphate transfer (De Bondt, et al., 1993). The N-terminal lobe is a 
binding surface for cyclins (Jeffrey, et al., 1995) and the C-terminal lobe is a 
binding surface for the Cks subunit (Bourne, et al., 1996). Before binding to a 
cyclin subunit, a large flexible region called the activation loop protrudes from 
the C-terminal lobe and blocks substrate entry (De Bondt, et al., 1993). The 
activation loop also contains a small L-helix that nudges toward the PSTAIRE 
helix, dispositioning the amino acids in the active site and preventing kinase 
activity (De Bondt, et al., 1993) (Fig. 2).  
Cdk activation combines two steps: a fast occurring T-loop phosphorylation 
(T160 in Cdk2 or T169 in Cdc28) and a rate-limiting binding of cyclin 
(Morgan, 2007). Both modifications are important to transition the Cdk-subunit 
from an inactive closed conformation to an active open conformation (Jeffrey, 
et al., 1995). Phosphorylated cyclin complexed Cdk has an open conformation, 
meaning that the N- and C-terminal domains are bent to open the cleft of the 
active site, the T-loop is displaced away to unblock the active site, and the L-
helix is completely disrupted or nudged away from the PSTAIRE-helix to 
arrange active site residues for catalysis (Jeffrey, et al., 1995; Brown, et al., 
2015) (Fig. 3). 
 
Figure 2. Ribbon diagram of the crystal structure of human Cdk2 without cyclin 
or the Cks subunit (PDB 1HCL). The N-terminal domain (dark green) contains the 
PSTAIRE-helix (light green). The C-terminal lobe is dark orange. The Cdk2 here 
represents the inactive conformation. The activator loop (blue) containing the L-helix 
and T-loop is blocking the entrance of the substrates into the active site (dark red) 
between the N- and C-terminal lobes. The activator phosphorylation site T160 in the  
T-loop is distinguished by stick-mode rendering. 
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The T-loop (or activator segment) is specifically phosphorylated by Cdk-
activating kinase (Cak) (Lolli & Johnson, 2005). In yeast, this step is carried out 
by a single monomeric Cak1 protein, and in mammals, it is carried out by a 
heterotrimeric cyclin-dependent kinase cyclin H-Cdk7-Mat1 (Kaldis, 1999). In 
both yeast and mammalian cells, Cak protein levels (Espinoza, et al., 1996), 
kinase activity (Sutton & Freiman, 1997) and localization (Kaldis, et al., 1998) 
are not affected by the cell cycle (Kaldis, 1999). Interestingly, the T-loop 
phosphorylation in human cells follows, and in yeast precedes, the binding of 
the cyclin subunit (Kaldis, 1999). The phosphorylation of the T-loop triggers its 
conformational loosening, which, in combination with cyclin binding, results in 
its displacement and release of the steric obstruction (Jeffrey, et al., 1995; 
Brown, et al., 2015) (Fig. 3). In addition, the phosphorylated T-loop offers a 
surface for the substrate recognition cleft and thereby determines the ability to 
recognize the optimal substrate consensus motif S/T-P-X-R/K via a pocket 
offered for +1 positioned proline and a contact between the positively charged 
amino acid of the substrate consensus motif and the activator phosphate of the 
Cdk loop (Brown, et al., 1999). 
In addition, cyclin binding to Cdk affects the conformation of the active site 
and its vicinity (Lolli, 2010). The surface on cyclin proteins interacting with 
Cdk is called the cyclin box, and it occupies a notable area around the 
PSTAIRE helix of the Cdk N-terminal lobe (Jeffrey, et al., 1995; Lolli, 2010) 
(Fig. 3). The cyclin box contains a bundle of five helixes within a region of 100 
amino acids and is conserved between all the major cyclins (Lolli, 2010). The 
binding of the cyclin box induces large conformational changes in the Cdk 
subunit by shifting the PSTAIRE-helix, bending the open active site of the cleft 
and aligning the catalytic amino acids of the active site to be able to catalyze 
phosphate transfer (Jeffrey, et al., 1995) (Fig. 3). As the cyclin subunit ex-
periences almost no conformational changes during the binding event, the Cdk 
subunit is virtually molded against the rigid cyclin surface (Jeffrey, et al., 1995). 
The sequence composition and structural features flanking the cyclin box are 
variable between different cyclins (Lolli, 2010). This divergence generates the 
cyclin-specific activation pattern of individual cyclin-Cdk complexes. For 
example, G1 cyclins are weak in forming contacts with the T-loop and 
controlling its conformation, whereas S-phase cyclins actively mold the T-loop 
by melting its L-helix and redirecting it via direct binding (Brown, et al., 2015; 
Day, et al., 2009; Takaki, et al., 2009) (Fig. 3). Additionally, G1-, S- and M-
phase cyclins provide structural differences to the MRAIL motif required for 
substrate recruitment for Cdk (Jeffrey, et al., 1995; Brown, et al., 2015; Day, et 
al., 2009; Brotherton, et al., 1998; Takaki, et al., 2009; Petri, et al., 2007). 
Finally, different cyclins are unique sites for posttranslational modifications and 
therefore allow different regulation by the cellular machinery (King, et al., 
1996; Clurman, et al., 1996; Won & Reed, 1996; Gallant, et al., 1995; Diehl, et 





Figure 3. Crystal structure of the activated cyclin-Cdk-Cks holoenzyme. Upper 
panel: human cyclin B-Cdk1-Cks2 holoenzyme with a ligand in the open Cdk 
conformation active site (PDB 4YC3, (Brown, et al., 2015)). Cyclin (green) binds to the 
Cdk N-terminal lobe (light orange) and its PSTAIRE-helix (dark orange), whereas Cks 
(olive green) binds to the C-terminal lobe (orange) of Cdk. The cyclin MRAIL-helix 
forms a floor for the hydrophobic substrate docking cleft (HP). Both the cyclin and Cks 
substrate docking pockets are accessible in the same direction to the Cdk active site. 
Bottom panel: crystal structures of human S-phase cyclin A-Cdk1 (PDB 1FIN, (Jeffrey, 
et al., 1995)) and early-G1-phase cyclin D3-Cdk4 (PDB 3G33, (Takaki, et al., 2009)) 
positioned in similar projections. Cyclin A and D fold the Cdk subunit to different 
extents. The active site of cyclin A-Cdk2 (contains dark red ligand) is more accessible 
for outer substrates than is cyclin D3-Cdk4 (no ligand present). The L-helix (blue) is 
weakly disturbed in Cdk4, and the T-loop (blue) is obstructing the entrance of the active 








2.4. The cyclin-dependent kinase inhibitors (Ckis) 
The function of the cyclin-dependent kinase inhibitors is to inhibit cyclin-
dependent kinase activity, and they act in an oscillatory manner, supporting the 
overall temporal organization of the cell cycle (Morgan, 2007). Ckis quench 
Cdk activity while finishing the previous cell cycle, maintaining the inhibited 
state for G0 arrest and the G1 phase, and regulating the release of Cdk activity 
upon entry into S phase (Morgan, 2007). 
The first Cki was discovered in yeast. S. cerevisiae Sic1 protein was found 
to be a tightly bound substrate of the cyclin-Cdk1-Cks1 complex (Reed, et al., 
1985). At the same time, Sic1 also acts as a nanomolar inhibitor for S-phase-
specific cyclin-Cdk1 kinase activity, but not for G1-specific cyclin-Cdk1 
activity (Mendenhall, 1993). The detectable expression and inhibitory activity 
of Sic1 protein is limited to G1 (Mendenhall, et al., 1987; Wittenberg & Reed, 
1988). The gene was named after substrate inhibitor of cyclin-dependent protein 
kinase Sic1 (Nughoro & Mendenhall, 1994). 
Although Sic1 transcripts can be detected at low levels across the cell cycle 
(Schwob, et al., 1994; Amoussouvi, et al., 2018) its expression is still cell-cycle 
regulated, peaking in late mitosis (Donovan, et al., 1994). In parallel, Sic1 
protein disappears at the G1/S transition and begins to reaccumulate in late 
mitosis (Donovan, et al., 1994; Schwob, et al., 1994). Sic1 contains 9 optimal 
and suboptimal Cdk sites and its degradation in G1/S is related to its 
hyperphosphorylation by Cdk kinases (Verma, et al., 1997) (Fig. 4).  
The analysis of deletion or overexpression phenotypes for Sic1 in yeast 
reveal defects in chromatin integrity and mitotic entry, suggesting a role in 
coordinating S- and M-phase Cdk activity at M/G1 and, more importantly, in 
G1/S transitions (Nughoro & Mendenhall, 1994; Schwob, et al., 1994; 
Donovan, et al., 1994). The presence of Sic1 in G1 is associated with inhibiting 
Clb5,6-Cdk1 activity and allowing its accumulation in the inhibited form prior 
to S-phase initiation (Schwob, et al., 1994; Schneider, et al., 1996). As dis-
cussed later, the basic function of Sic1 is to control the timely release of  
S-phase Cdk activity to facilitate coordinated and irreversible initiation of DNA 
replication (Lengronne & Schwob, 2002; Schwob, et al., 1994). Sic1 is sug-
gested to be a mammalian p21cip1 or p27kip1 functional homolog (Peter & 
Herskowitz, 1994; Barberis, et al., 2005). 
In mammalian cells, there are two families of Cki proteins that regulate the 
activity of Cdks: INK4 and CIP/KIP. The INK4 (Inhibitors of CDK4) family 
consists of four proteins: p16INK4a (Serrano, et al., 1993), p15INK4b (Hannon & 
Beach, 1994), p18INK4c (Guan, et al., 1994; Hirai, et al., 1995), and p19INK4d 
(Chan, et al., 1995; Hirai, et al., 1995). They specifically modulate Cdk4- and 
Cdk6-dependent kinase activity at G0 or during the early stage of G1 (Sherr & 
Roberts, 1999). The CIP/KIP family (Cdk interacting protein/Kinase inhibitory 
protein) contains three proteins: p21cip1/waf1 (Gu, et al., 1993; Xiong, et al., 1993; 
Harper, et al., 1993), p27kip1 (Toyoshima & Hunter, 1994; Slingerland, et al., 
1994; Polyak, et al., 1994), and p57kip2 (Matsuoka, et al., 1995; Lee, et al., 
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1995). These inhibitors modulate cyclin-Cdk activity during G1, the G1/S 
transition and at the onset of G1 after completion of the previous mitosis (Sherr 
& Roberts, 1999). The INK4 family of inhibitors is robust and specifically 
targets the Cdks early in the cell cycle to attain a complete inhibition of G0 or 
early G1, while the CIP/KIP family of inhibitors contains more versatile modu-
lators of cyclin-Cdk activities across the cell cycle (Sherr & Roberts, 1999). 
Contrary to mammalian cells, in S. cerevisiae cells, G1 Cdk activity is con-
ditionally inhibited upon mating (pheromone pathway activation), starvation or 
extreme stress. In haploid yeast cells, the presence of the mating pheromone  
α-factor induces Far1, which inhibits G1-cyclin Cdk activity (Chang & 
Herskowitz, 1990). Additionally, if cells experience phosphate starvation, a 
nutrient-sensitive inhibitor Pho81 will target a particular Cdk called Pho85 in 
the G1 phase (Schneider, et al., 1994). A stress-activated Cln1-3 inhibitor Cip1 
has been discovered (Ren, et al., 2016; Chang, et al., 2017). Of these, only the 
Pho81 inhibitory domain is considered similar to the mammalian INK4 family 
of inhibitors (Schneider, et al., 1994). With no stress or pheromones present, the 




2.5. Structural properties of Sic1 
Sic1 (Brocca, et al., 2009; Mittag, et al., 2008; Liu, et al., 2014; Mittag, et al., 
2010) and the mammalian KIP/CIP family proteins p21cip1 (Kriwacki, et al., 
1996) and p27kip1 (Bienkiewicz, et al., 2002) are intrinsically disordered proteins 
(IDPs) that do not adopt a stable secondary or tertiary fold in the free solution 
state. As an isolated molecule in solution, Sic1 adopts a variety of extended and 
compacted forms that alternate dynamically in the timescale of molecular dif-
fusion (Liu, et al., 2014). Such intrinsic disorder is a common property of proteins 
involved in signal transduction (Dunker, et al., 2005; Daughdrill, et al., 2008). 
Structural disorder in solution or a dynamically volatile structure characterize a 
broad class of regulatory proteins or loops of otherwise structured proteins, 
including many inhibitory proteins (Lee, et al., 2014; Wright & Dyson, 2009; 
Galea, et al., 2008). 
In its primary structure, Sic1 contains 284 amino acids. The kinase inhibitory 
domain (KID) of Sic1 is located in a 70 amino acid-long stretch in its  
C-terminus (Hodge & Mendenhall, 1999) (Fig. 4). The N-terminal region of 
159 amino acid comprises a multiphosphorylation pathway together with 7 opti-
mal Cdk phosphorylation sites and is necessary for Sic1 Skp1/Cdc4-dependent 
destruction mediated by the SCFCdc34 ubiquitin ligase during the G1/S transition 
(Verma, et al., 1997; Verma, et al., 1997). Another two optimal Cdk sites together 
with a casein kinase 2 (Ck2) consensus site were located in the  
C-terminal region right before the Cdk inhibitory domain (T173, S191 and 
S201, respectively, Fig. 4). The role of the secluded Cdk sites at the C-terminal 
has been addressed recently and will be discussed later, whereas the S201 site in 
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Sic1 is a target for Ck2, and its phosphorylation is related to Clb5,6-Cdk1 
accumulation in G1, suggesting a role in the functioning of the Sic1 KID 
(Coccetti, et al., 2004). 
 
Figure 4. Domain organization of S. cerevisiae Sic1 and human p27 relative to 
primary amino acid sequences. Both proteins contain a kinase inhibitory domain 
(KID, blue) and a regulatory domain (orange) containing multiple phosphorylation input 
sites (sticks with circles). A conserved K/RXLF sequence motif is located at one end of 
the KID (red). Other R/KXL motifs are located in the KID and are marked as open 
boxes (orange). Sic1 contains at least 10 identified phosphorylation input sites, whereas 
p27 contains at least 8 (Lu & Hunter, 2010). In addition to phosphorylation sites, seve-
ral cyclin docking motifs (R/KXL and VLLPP) have been noted for Sic1 (light orange). 
The cyclin docking sites in the regulatory part (if existent) are left unmarked in p27. If 




The KID of Sic1 was mapped by using Sic1 9-AP version with all optimal Cdk 
sites mutated to alanine (Hodge & Mendenhall, 1999). The overexpression of 
such mutations causes yeast cells to arrest in G1 with elongated multiple bud 
morphology, indicating that Clb5,6-Cdk1 activity is inhibited while Cln1-3-
Cdk1 activity is unperturbed (Dirick, et al., 1995; Mendenhall, 1993). By gene-
rating a series of truncations of stable Sic1, cellular arrest was maintained only 
if the C-terminal region between 215 and 284 was intact (Hodge & Mendenhall, 
1999). Deletions exceeding position 215 and deletion of most of the C-terminal 
stretch of 11 amino acids starting from position 273 lead to a loss of cell cycle 
arrest (Hodge & Mendenhall, 1999). 
 
 
2.5.1. Inhibitory domains of Sic1 and human p27 
The mechanism of how Cki proteins inhibit their targets is revealed in detail for 
mammalian p27 (Russo, et al., 1996; Bienkiewicz, et al., 2002; Lacy, et al., 
2004; Sivakolundu, et al., 2005; Otieno & Kriwacki, 2012). In p27, the KID is 
mapped onto the N-terminal of the protein (region at positions 22–104, Fig. 4) 
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(Russo, et al., 1996). The domain contains an unstructured N-terminal domain 1 
(D1) and a C-terminal domain 2 (D2) spaced by a linker helix (LH), that consti-
tute the only distinguishable secondary structure of the protein (Bienkiewicz, et 
al., 2002; Lacy, et al., 2004) (Fig. 5).  
Binding to cyclin A-Cdk2 takes place in a multistep manner (Lacy, et al., 
2004). The first interaction forms rapidly between the small and highly dynamic 
D1 and the cyclin subunit (Lacy, et al., 2004). The RXLFG sequence motif 
from D1 binds into the substrate recruitment cleft of cyclin A at the MRAIL-
helix (Russo, et al., 1996; Lacy, et al., 2004) (Fig. 5). The interaction results in 
almost no conformational changes to the cyclin-Cdk complex but is necessary 
to fold the linker helix of KID, which in turn directs D2 to bind Cdk2 (Lacy, et 
al., 2004). Only after this step do slow but comprehensive structural changes 
result, forming a ternary inhibitory complex (Lacy, et al., 2004). In this 
complex, D1 blocks the cyclin substrate recruitment site, and the small 310-helix 
from D2 occupies the Cdk active site by substituting ATP and shielding the 
activator tyrosine residue for Cak (Russo, et al., 1996; Lacy, et al., 2004) (Fig. 5). 
The RNLFG sequence in p27 is important for the recruitment of the inhibitor 
to initiate its folding (Lacy, et al., 2004; Ou, et al., 2011). The multiple 
sequence alignment of Sic1 KID with the corresponding region of the fission 
yeast S. pombe functional homolog Rum1 (Sánchez-Díaz, et al., 1998) shows a 
conserved similar R/KXL sequence at the C-terminal end (Fig. 5). Additionally, 
the Sic1 KID contains one more R/KXL motif in its C-terminal region. Hodge 
and Mendenhall tested both of them, as the KXL at position 260 was disturbed 
by introducing point mutations and the C-terminal KALF was removed by the 
truncation starting from position 274, and they found that both mutations result 
in the loss of arrest in overexpressed Sic1-9AP (Hodge & Mendenhall, 1999). S. 
pombe Rum1 only contained the conserved C-terminal R/KXLF motif (Fig. 5). 
Another similarity to the p27 KID is that the middle of the KID Sic1 in 
solution exhibited a similar short α-helical preorganized secondary structure 
with a similar amphiphilic profile (Brocca, et al., 2009; Barberis, et al., 2005; 
Bienkiewicz, et al., 2002). The p27 linker helix, despite having almost no 
sequence homology to the other CIP/KIP family members, demonstrated a 
conserved secondary structure and dynamic properties (Sivakolundu, et al., 
2005). The structure of this helix is crucial to the correct folding of the inhibitor 
to the cyclin-Cdk complex (Otieno & Kriwacki, 2012). Therefore, it has been 
suggested that the Sic1 KID could bind the cyclin-Cdk complex in a manner 
similar to that of p27 (Barberis, et al., 2005). 
The positioning of the KID in proteins and the order of the KID components 
in S. cerevisiae, S. pombe and p27 are relatively different. In Sic1, the KID is  
C-terminally located (Hodge & Mendenhall, 1999), whereas in Rum1, it is 
located in the center of the protein (positions 87–147) (Sánchez-Díaz, et al., 
1998). In p27, the KID is located in the N-terminal part of the protein (Russo, et 
al., 1996). In Sic1 or Rum1, the positioning of potential conserved recruitment 
of the RXL motif with respect to the linker helix is reciprocal compared with 
that of p27 (Fig. 5).  
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At its C-terminal end, the p27 KID contains phosphorylation sites (Y74 and 
Y88) that affect its function (Grimmler, et al., 2007; Chu, et al., 2007; Ou, et al., 
2012) (Fig. 4 and 5). In Sic1, no such phosphorylation sites have been identified 
yet, although a casein kinase 2 (Ck2) target (S201) in the N-terminal vicinity of 
the KID (Fig. 4) affected its inhibitory function for S-phase cyclin activity in 
vivo (Coccetti, et al., 2004). The site is missing in S. pombe Rum1. A Ck2 target 
site (S83) is positioned in D2 of the p27 KID domain, and thus, its phosphory-
lation could possibly alter its inhibitory function (Tapia, et al., 2004; Rath & 
Senapati, 2016). 
  
Figure 5. Yeast KID is similar to mammalian p27 but has reciprocal domain 
architecture. Upper panel: multiple sequence alignment of S. cerevisiae Sic1 KID 
(positions 215–281) and S. pombe Rum1 KID (positions 89–149) produced by 
MUSCLE (3.8) using default options. Similar amino acid positions are highlighted in 
gray. The conserved R/KXLF region indicated in blue and the corresponding sequence 
from human p27 were aligned. PHD and PSIDRED predicted α-helical structures, 
marked by rectangles. Middle panel: p27 kinase inhibitory domain from positions 28 to 
91. The RXLFG sequence is highlighted in blue. Domain D1 and domain D2 are noted 
by a line with a circle. A helical secondary structure assessment from (Bienkiewicz, et 
al., 2002; Lacy, et al., 2004). The RXLFG motif binds the cyclin subunit HP at MRAIL-
helix and the 310-helix binds to the Cdk catalytic site. Tyrosine residues Y74 and Y88 
are indicated in orange. Bottom panel: ternary inhibitory complex of the p27 KID with 
cyclin A-Cdk2, crystal structure (1JSU, (Russo, et al., 1996)). Cyclin subunit colored in 
green, Cdk2 in orange and the p27 KID in red. The RNLF motif and Y74 and Y88 sites 
are represented as dotted spheres. The surrounding amino acids at Y74 are part of the 
310-helix in D2. 
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Attempts have been made to inhibit human cyclin A-Cdk2 with Sic1, but the 
measured Kd values for cyclin A-Cdk2 binding (Barberis, et al., 2005) are two 
orders of magnitude weaker than those with p27 (Bienkiewicz, et al., 2002; 
Lacy, et al., 2004) (Table 2). In accordance with Ki measurements using H1 as a 
model substrate, Sic1 acts on cyclin A-Cdk2 as a competitive inhibitor forming 
much looser contacts than p27 does (Barberis, et al., 2005; Lacy, et al., 2004). 
 
Table 2. Kd values of Sic1 and p27 binding to the human cyclin A-Cdk2 complex. 
Cdk component Kd (nM), SPR* Kd (nM), ITC* Kd (nM), SPR* 
Cdk2 19000 70 248 
cyclin A 5100 25 50 
cyclin A-CDK2 200 3,5 4,4 
Reference (Barberis, et al., 2005) (Lacy, et al., 2004) (Grimmler, et al., 2007) 
* SPR – Kd measured by surface plasmon resonance with an immobilized inhibitor; ITC – Kd 
measured in solution by isothermal titration calorimetry. 
 
It is doubtful whether Sic1 is able to trigger similar conformational changes in 
cyclin A-Cdk2 as p27 does. However, despite the lack of strong binding to 
cyclin A-Cdk2, nanomolar binding with the native interaction partner of Sic1, 
Clb5-Cdk1, takes place (Mendenhall, 1993). The common unstructured feature 
and cryptic helical region of the KID and the tight inhibition suggest that upon 
binding to Clb5-Cdk1, Sic1 induces similar comprehensive structural folding of 
its Cdk partner. Internal disorder itself is one of the common mechanisms 
related to the folding of cyclin-Cdk complexes, despite the differences in 
specific docking contacts. 
 
 
2.6. The N-terminal phosphorylation pathway and  
Sic1 destruction 
During the G1/S transition, Sic1 protein is degraded via SCFCdc34-mediated 
proteolysis (Schwob, et al., 1994). The proteolysis of Sic1 is orchestrated by 
phosphorylation-dependent recognition of Sic1 by the Cdc4-Skp1 phospho-
adaptor subunit of the SCFCdc34 complex (Verma, et al., 1997; Verma, et al., 
1997; Feldman, et al., 1997; Skowyra, et al., 1997). The multiphosphorylation 
mechanism of Sic1 protein leading to binding of Cdc4 as an output has led to 
grown interest in the dynamics of Sic1 phosphorylation and the binding 






2.6.1. Sic1 phosphorylation and degradation 
Achieving irreversibility of the G1/S transition while simultaneously main-
taining control over the timing of this process is an essential requirement of cell 
cycle regulation (Nasmyth, 1995; Tyson, et al., 1995). The phosphorylation and 
subsequent degradation of Sic1 is a key event in the G1/S transition and, as 
demonstrated, requires Cdk1 kinase activity (Dirick, et al., 1995; Tyers, 1996; 
Schneider, et al., 1996). As Clb5,6-Cdk1 activity is blocked in G1 by Sic1 
inhibition, Cln1-3-Cdk1 has been suggested to be mainly responsible for 
phosphorylating Sic1 and sending it into degradation (Dirick, et al., 1995; 
Tyers, 1996; Schneider, et al., 1996). On the other hand, Cln1-3 activity is 
available far before Sic1 degradation and initiation of S phase (Tyers, et al., 
1993). Therefore, how cells delay Sic1 degradation, and more importantly, how 
they manage the abrupt and timely degradation of Sic1 for the proper initiation 
of S phase (Lengronne & Schwob, 2002; Schwob, et al., 1994) with relatively 
slow accumulating G1 enzymes is controversial. 
The hypothesis that Cln1-3 are responsible for Sic1 degradation was tested 
by genetic studies with yeast strains lacking Cln1-2. In such strains, either Cln3 
overexpression or Sic1 deletion is necessary for rescue from G1 arrest (Dirick, 
et al., 1995; Tyers, 1996; Schneider, et al., 1996). Minimal attention has been 
paid to the fact that the rescue of Sic1 on a Cln1-3 deletion background is 
offered by ectopically overexpressing the S-phase cyclin Clb5 (Epstein & 
Cross, 1992; Schwob & Nasmyth, 1993). In addition, native expression of Clb5 
is Cln3-dependent through the activation of MBF-related transcription (Tyers, 
et al., 1993; Dirick, et al., 1995; Stuart & Wittenberg, 1995). All that Cln3 over-
expression offers is early activation of Clb5, which at some point simply leads 
to levels of Clb5 that exceed those of Sic1 and therefore promote Sic1 
phosphorylation and release from the arrest. Thus, Cln3 overexpression might 
rescue Sic1 by changing its activity on Clb5 transcription. In addition, Cln3 
enhances the transcription of Pcl1,2 cyclins of Pho85, which, when over-
expressed, contribute significantly to Sic1 degradation (Nishizawa, et al., 1998). 
An elegant biochemical demonstration of Sic1 poly-ubiquitination is pre-
sented by Verma, Feldman, Skowyra and colleagues who successfully reconsti-
tuted SCFCdc34-dependent ubiquitin ligase activity in vitro (Verma, et al., 1997; 
Verma, et al., 1997; Feldman, et al., 1997; Skowyra, et al., 1997). They demon-
strate that for Sic1 ubiquitination in vitro, extensive phosphorylation by purified 
Cln2-Cdk1, Clb2-Cdk1 (Verma, et al., 1997; Feldman, et al., 1997) or Clb5-
Cdk1 (Feldman, et al., 1997; Skowyra, et al., 1997) complexes is necessary. 
However, the kinetic parameters of the phosphorylation reactions performed did 
not allow the quantitative assessment of cyclin specificity in connection with 
the Sic1 ubiquitination reaction. Verma, Feldman, Skowyra and colleagues 
demonstrated that for Sic1 ubiquitination, phosphorylation at multiple N-
terminal sites in the region of 1–105 are necessary (Verma, et al., 1997), 
especially the sets containing T33, T45 and S76 (Verma, et al., 1997) or T5, 
T45 and S76 (Feldman, et al., 1997) and that these sites are crucial for binding 
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Cdc4-Skp1 (Feldman, et al., 1997). Moreover, ubiquitination of Sic1 does not 
depend upon its binding to the Clb5-Cdk1 inhibitory complex (Verma, et al., 
1997), and ubiquitination successfully dislodges Sic1 from the Clb5-Cdk1 inhi-
bitory complex (Feldman, et al., 1997) by releasing the functional Clb5-Cdk1 
complex (Verma, et al., 2001). 
Albeit these studies prove that Sic1 degradation is phosphorylation-depen-
dent and requires the SCFCdc34 pathway, it remains an open question through 
which kinases and by which dynamics the Sic1 multiphosphorylation process 
leads to its destruction. These questions are addressed in detail in the Results 
and discussion section. 
 
 
2.6.2. Sic1 binding specificity to the Cdc4SCF subunit 
The important question in the regulation of Sic1 degradation is related to the 
binding specificity of Cdc4 and has been a much-debated subject during the past 
decade. No single Cdk site in Sic1 possesses the optimal consensus sequence 
for Cdc4 binding (Nash, et al., 2001) and is insufficient for Sic1 degradation in 
vivo (Verma, et al., 1997; Nash, et al., 2001). For in vivo Sic1 destruction, a set 
of multiple sites must be phosphorylated (Nash, et al., 2001). Initially, Cdc4 
binding was expected to take place through single optimal TP or SP sites (Nash, 
et al., 2001; Orlicky, et al., 2003) but the lack of optimal binding sites in Sic1 
and its multiphosphorylation suggested an allovalent binding model. This model 
states that Cdc4 is able to multiply six nonoptimal sites in phosphorylated Sic1 
into high affinity dynamic binding equilibrium: the allovalent interaction 
(Klein, et al., 2003; Nash, et al., 2001). The allovalency of Cdc4 was soon chal-
lenged by structural studies of phosphorylated substrates bound to the human 
Cdc4 homolog Fbw7 and later to Cdc4 itself (Wu, et al., 2003; Hao, et al., 2007; 
Csizmok, et al., 2017) and by detailed analyses of Sic1 phosphorylation 
pathways (reviewed in the Results and discussion section). 
The main confusion about Cdc4 binding to Sic1 arises from the propeller-
shaped WD40 substrate recruitment domain of Cdc4 that recruits substrates via 
many different binding modes. For example, optimal degron in human cyclin E 
at T380 can interact both via single phosphorylated threonine (LLTPPQSG) 
(Orlicky, et al., 2003) and via a doubly phosphorylated form of the same motif 
(LLTPPQSG) (Hao, et al., 2007). As shown by Hao and colleagues, the first 
interaction generated a Kd of approximately 1 µM and the second interaction 
generated a Kd of approximately 0,07 µM (70 nM) (Hao, et al., 2007). The 
main phosphorylated threonine, pT380, inserts itself into a positively charged 
pocket in the central part of the WD40 domain whereas auxiliary S384 makes 
additional contact through the distal positively charged surfaces (Hao, et al., 
2007; Welcker & Clurman, 2007; Csizmok, et al., 2017). Moreover, in the case 
of a single phosphorylated threonine in human cyclin E, the dimerization of 
Fbw7 improves the binding affinity of the protein over the monomeric form, 
whereas doubly phosphorylated degron restricts Fbw7 dimerization (Welcker & 
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Clurman, 2007). Similarly, yeast Cdc4 forms dimers, and although dimerization 
do not appear to enhance the binding affinity of phosphorylated Sic1, it is 
indispensable for its ability to process Sic1 for destruction in vivo (Tang, et al., 
2007). 
With Sic1, the binding affinity (Kd) of single site phosphorylated forms of 
Cdc4 fall into the range of 10–100 µM (Orlicky, et al., 2003). In contrast, Sic1 
peptides with certain diphosphorylated sites, called double degrons, at either 
combinations of pT5/pT9, pT45/pS48 or pS76/pS80, bind Cdc4 with an affinity 
below 4 µM (Hao, et al., 2007). Further, full-length Sic1 phosphorylated from 
multiple Cdk sites bind Cdc4 with a Kd of approximately 1 µM, which is 
sufficient for Sic1 degradation in vivo (Orlicky, et al., 2003; Hao, et al., 2007; 
Tang, et al., 2012; Csizmok, et al., 2017). It is important to add that full-length 
phosphorylated Sic1 preparations used in binding assays (Orlicky, et al., 2003; 
Mittag, et al., 2008; Csizmok, et al., 2017; Hao, et al., 2007) contain the largest 
populations of Sic1 with 6-phosphates (T5, T33, T45, S69, S76, and S80). As 
these preparations exclude T9 or T48 from the assay, they are limited to only 
one fully phosphorylated double degron S76/S80 (Mittag, et al., 2008). 
NMR (nuclear magnet resonance) studies using a p69/pS76/pS80 triply 
phosphorylated peptide demonstrate that Sic1 binds Cdc4 through two 
phosphates, although S69 might negatively interfere with the positioning of S76 
in the main phosphate binding pocket (Csizmok, et al., 2017). Unfortunately, 
there are no available affinity or structural studies for Sic1 that simultaneously 
encompass both pairs (pT45/pS48 and pS76/pS80) of high-affinity degrons to 
form contacts with a Cdc4 monomer or dimer. Therefore, how Cdc4 exposes 
Sic1 for fast ubiquitination in vivo remains a question open for discussion. 
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3. STUDY OBJECTIVES 
Although cyclins and Cdks have been known as master regulators of cell cycle 
for decades, we still do not understand how they coordinate the complex events 
of cell division involving temporal resolution in the regulation of hundreds of 
substrates. One of the major enigmas in this research field has been the 
phenomenon of multisite phosphorylation. The vast majority of Cdk targets are 
phosphorylated at multiple sites at disordered regions, but the mechanism and 
logic of the signal processing is a mystery. Moreover, it is unknown whether the 
linear patterns of phosphorylation sites and kinase docking sites carry a certain 
code for Cdk signal processing and the temporal ordering of the cell cycle 
events. An intrinsically disordered protein, Sic1, a multisite target of Cdk and a 
G1/S transition point, serves as one of the central model systems for studying 
Cdk function and multisite phosphorylation. The general objective of this study 
is to unveil the Sic1 multisite phosphorylation mechanism and its role in the 
G1/S switch. The specific objectives of this study are listed below. 
1) To map the phosphorylation specificity in yeast cyclin-Cdk complexes with 
respect to the specificity of the Cdk active site and cyclin-dependent 
docking (I). 
2) To investigate the dynamics of multisite phosphorylation of Sic1 and to 
analyze the specific roles of G1- and S-Cdk complexes in Sic1 phosphory-
lation and degradation in G1/S. Critical evaluation of the distributive 
multisite phosphorylation model as s general basis of ultrasensitivity of the 
cell cycle switches (II, III, IV). 
3) To perform a systems level analysis of Sic1 degradation at the G1/S switch 
based on biochemical evidence gathered in paper II. 
4) To define the biochemical parameters controlling the multisite phosphory-
lation of target proteins by yeast cyclin-Cdk1-Cks1 complexes (III, IV). 
5) To study the role and mechanism of intracomplex phosphorylation in cont-
rolling the dynamics of Sic1 degradation and the G1/S transition (V). 
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4. MATERIALS AND METHODS 
Recombinant cyclin-dependent kinase holoenzyme complexes for in vitro 
characterization were purified from S. cerevisiae carrying an Δsic1 allele by 
using ectopic galactose promoter-driven overexpression of tagged cyclin as in 
Ref. I and as described for the Clb1-5 cyclins and for Cln2(Puig, et al., 2001; 
Ubersax, et al., 2003) (McCusker, et al., 2007). The presence of the Cks1 
subunit in the complex and the optimal Cks1 concentrations for the in vitro 
kinase assay are described in Ref. II Supplementary Fig. 1, and purification was 
carried out as described in (Reynard, et al., 2000). Sic1, Sic1ΔC and other 
substrate proteins were purified as 6xHis tagged recombinant proteins from E. 
coli as described in Ref. I. 
The composition and setup of in vitro kinase assays for assessing Michaelis-
Menten kinetics in Ref. I–III is described in Ref. II. The intracomplex 
phosphorylation assay for Clb5-Cdk1-Cks1 used in Ref. IV–V is described in 
Ref. V. For quantifying the phosphorylation signals, trace amounts of  
[γ-32P]ATP (Perkin Elmer) were used, with a final activity of 0,1 mCi/ml for 
Michaelis-Menten kinetics and 1 mCi/ml for the intracomplex phosphorylation 
assay. For signal quantification, a Typhoon 9410 GE Healthcare phosphoimager 
and its software was used. 
For the quantitative titration of the intramolecular phosphorylation signal to 
reveal the number of phosphates added per molecule of bound Sic1 in Ref. V, 
the parallel full phosphorylation of the Cdk1 subunit from its inhibitory site, 
Y19, was used as a standard. The full phosphorylation was assessed by using 
excess amounts of Swe1-TAP purified kinase (1 µM) cross-checked by the 
residual activity of a targeted Clb5-Cdk1 pool (Ref. V, Supplementary Fig. 
1b,c). 
For running denaturing PAA gel electrophoresis, standard methods were 
used. To separate phosphorylated isoforms by using denaturing PAA gels, a 
phosphate-binding ligand (PhosTag, 100 µM final concentration) with Mn2+ 
was used to supplement the separation of the gel according to the manufac-
turer’s instructions. Gels were run at 15 mA per 0,75 mm for 3 hours. 
Mass spectrometry analysis for intramolecularly phosphorylated Sic1 was 
carried out as described in Ref. II. For the assay, the intracomplex phosphory-
lation mixture was separated on a denaturing SDS-PAA gel, and the Sic1 band 
was excised for further in-gel protease digestion. 
An isothermal calorimetry assay was performed in collaboration with Seth 
Rubin’s group as described in Ref. II and Ref. III. To phosphorylate the Sic1ΔC 
protein, Clb2-Cdk1 enzyme without added Cks1 was used, as described in Ref. 
II. 
For yeast culturing for Western blot or viability assays, standard procedures 
were followed. For pheromone treatment, the synthetic pheromone peptide was 
dissolved in DMSO in 10 mg/ml (approximately 5,9 mM) concentration as a 
stock solution and stored at –80°C. For yeast strains carrying the bar1– allele, a 
29 
final concentration of 0,59 µM was used. For yeast strains with the Bar1+ allele, 
a final concentration of 5,9 µM was used. The strains and plasmids used in 
these experiments are all listed in the supplementary information of Ref. I – V. 
The viability spotting assay is described in the Materials and Methods 
sections of Ref. I – III. The process of yeast FACS analysis is described in Ref. 
I. The microfluidics assay is described in Ref. V and by (Doncic, et al., 2011). 
Experimental conditions for Cln1-3 shutdown strains are described in Ref. V. 
Fluorescent image quantification was performed as described in (Doncic, et al., 





5. RESULTS AND DISCUSSION 
5.1. Characterization of cyclin-CDK substrate specificity  
in S. cerevisiae (Ref. I) 
As demonstrated by Loog and Morgan, yeast Clb5-Cdk1 and Clb2-Cdk1 
complexes have differences in overall intrinsic kinase activity and substrate 
specificity (Loog & Morgan, 2005). Although Clb5-Cdk1 has a lower intrinsic 
kinase activity (lower kcat and higher Km values toward peptide substrates) than 
that of Clb2-Cdk1, it benefits over the latter from substrate recruitment by the 
cyclin hydrophobic patch (HP) region to bind substrate RXL motifs (Loog & 
Morgan, 2005). The hydrophobic patch motif is located in the MRAIL-helix 
region of Clb5 (Bazan, 1996) and is attributed to the S-phase-specific activity of 
Clb5, the activity of which is not replaceable by ectopically expressing Clb2 
instead (Cross, et al., 1999). Similarly, the G1- and S-phase cyclins Cln2 and 
Clb5 have divergent roles, as Cln1-3 activity is able to initiate budding but is 
unable to initiate the replication; the latter function is attributed to Clb5-Cdk1 
(Dirick, et al., 1995; Mendenhall, 1993). Differences in enzyme specificities 
might underlie the temporal resolution and timing of different cell cycle events, 
including the multiphosphorylation of Sic1. 
In this study, we assessed the enzyme specificity of representatives of all 
four classes of the yeast cell cycle-related Cdk complexes: Cln2-, Clb5-, Clb3- 
and Clb2-Cdk1 complexes, toward Sic1. Each of the cyclins activates the Cdk1 
active site to a different extent. Strikingly, the intrinsic activity toward short 
optimal model peptides gradually rose in the order of the appearance of the 
cyclins in the cell cycle (Ref. I, Fig. 1). The early cell cycle cyclins, Cln2 and 
Clb5, provided relatively low Cdk1 activity compared with that of the mitotic 
cyclin Clb2 (Ref. I, Fig. 1). The gradual increase in the means of the kcat/Km 
value was most pronounced in the Km component and was the result of Cdk1 
activation by different cyclin subunits and not the result of different 
posttranslational modifications of Cdk1 (Ref. I, Fig. 1 and Supplementary 
Fig. S2). 
However, the noninhibitory Sic1ΔC protein demonstrates an almost mirrored 
profile of the different cyclin-Cdk1 activities, with the highest activity origi-
nating from Clb5-Cdk1 (Ref. I, Fig. 3C). We found that in the case of Sic1, 
early cyclin-Cdk1 complexes compensate their gradually lower intrinsic activity 
toward consensus phosphorylation by specific docking motifs (Ref. I, Fig. 2, 
Fig. 3, Supplementary Fig. S1). Most importantly, we discovered a docking 
motif for G1-Cdk complexes, a short hydrophobic motif starting at position 136 
in Sic1 (Ref. I, Fig. 3). The VLLPP region was simultaneously identified by the 
Pryciak group (Bhaduri & Pryciak, 2011) and later shown to interact with a 
region in Cln2 not homologous to the substrate recruitment pocket found in 
Clb5 (Bhaduri, et al., 2015). As demonstrated by us, Cln2-Cdk1 preferentially 
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targets the T5, T33 and S76 sites in Sic1 and for this substrate recruitment 
through the VLLPP motif is crucial (Fig. 6; Ref. I, Fig. 3). 
Moreover, we demonstrated that different cyclin-Cdk1 complexes diverged 
in the requirements for the amino acid composition of the consensus substrate 
motif (Ref. I, Fig. 4, Supplementary Table S1). The differences are particularly 
pronounced between Cln2 and Clb5-Cdk1. Cln2-Cdk1 strongly preferred a +2 
positioned lysine and a –2 positioned proline from the targeted S/T consensus, 
whereas Clb5 was much more tolerable to the surrounding amino acids (Ref. I, 
Fig. 4, Supplementary Table S1). Therefore, the intrinsic Cln2-Cdk1 kinase 
activity toward different S/TP sites in Sic1 is much more divergent than it is by 
Clb5-Cdk1 (Ref. I, Fig. 4D). 
In agreement with the gradual compensation of early cyclins by docking 
motifs, Clb5-Cdk1 activity toward the noninhibitory version of Sic1 was largely 
led through the R/KXL substrate motifs (Fig. 6; Ref. I, Fig. 2, Fig. 3). Different 
RXL sites on Sic1 led to site-specific engagement of Clb5 docking, as T33 
phosphorylation was dependent on the 2nd and 3rd R/KXL motifs (positions 89–
91 and 114–116, respectively), and S76 phosphorylation was exclusively 
dependent on the 3rd R/KXL motif (Fig. 6; Ref. I, Fig. 2). Moreover, the 2nd and 
3rd RXL motifs are crucial for rescue from cell cycle arrest induced by Sic1 
overexpression (Ref. I, Fig. 5). In addition, RXL-mutated Sic1 has a 10 min 
degradation timing delay in release from pheromone-induced G1 arrest. (Ref. I, 
Fig. 5). 
Finally, we screened a set of proteins containing multiple potential Cdk 
target phosphorylation sites with all four cyclin-Cdk1 kinases in vitro. Most of 
the substrates were regulated in a cell cycle-dependent manner. The groups of 
substrates with vast differences in phosphorylation profiles among the cyclin-
Cdks were identified (Ref. I, Fig. 6). The early cell cycle cyclins Cln2 and Clb5 
are most dependent on VLLPP or K/RXL docking respectively. Clb3 has an 
intermediate effect, and Clb2 is relatively independent of RXL docking. A 
group of substrates follow a gradual specificity profile among different cyclin-
Cdks similar to the model substrate histone H1. 
Our results demonstrate that during the progression of the cell cycle, dif-
ferent cyclins gradually add the intrinsic kinase activity of Cdk1. However, 
additional mechanisms exist to target substrates via cyclin docking motifs. This 
aspect is especially important for early cell-cycle events where low intrinsic 
Cdk activity copes with vast amounts of potential targets and selectively 
phosphorylates a subset of substrates. The gradually changing specificity model 
in combination with cyclin-specific docking and substrate consensus prefe-
rences uncovered in this study lay the groundwork for the general unified model 
of Cdk function in the cell cycle that combines both elements of the quantitative 
threshold model (Stern & Nurse, 1996; Hochegger, et al., 2008; Swaffer, et al., 
2016) and the cyclin specificity model (Bloom & Cross, 2007; Kõivomägi & 
Skotheim, 2014).  
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Figure 6. Cln2 and Clb5 provide different docking sites for Cdk1 activity. Sic1  
N-terminal domain (orange) contains a multiple phosphorylation input sites (sticks with 
circles, targeted amino acid position noted by a number) and several cyclin docking 
motifs (R/KXL and VLLPP, light orange boxes). Cln2 uses a single VLLPP consensus 
motif to target N-terminal phosphorylation sites of Sic1. Docking-phosphorylation 
routes of Cln2 are marked with light blue lines and for Clb5 dark blue lines. The 
herringbone-shaped end is for docking and arrowhead end for target phosphorylation, 
bold arrowhead for main target site, dotted line for auxiliary target sites. Clb5 mainly 
uses two specific K/RXL motifs (RTL and RIL sequences) in Sic1 to target N-terminal 
phosphorylation sites. Note that for Clb5 such docking interactions are mainly available 
if KID is removed or if Clb5 is in excess of Sic1 (see figure 8). 
 
 
5.2. The cyclin and Cks1 double docking mediates the 
sequential mechanism of the multisite phosphorylation  
of Sic1 (Ref. II and IV) 
As previously proposed, phosphorylation of a random selection of 6 phosphory-
lation sites in Sic1 by the G1-Cdk complex leads to the ultrasensitive degra-
dation dynamics of Sic1 at the G1/S transition (Nash, et al., 2001). The model 
was based on the assumption that the apparent affinity of the multiply-
phosphorylated Sic1 with SCF-Cdc4 is increased via a multivalent interaction 
involving dynamic association and dissociation of all six sites with a single 
pocket on Cdc4. Although the side of the model addressing the interaction with 
Cdc4 had already received some criticism from structural biologists (Hao, et al., 
2007), the element of Cdk phosphorylation dynamics was entirely ignored by 
Nash et al (Nash, et al., 2001). The main problem with it was that the assumed 
ultrasensitive dose-response was only possible in the case when the multisite 
phosphorylation was entirely distributive, meaning that each site is phosphory-
lated in a random order and independent of each other (Klein, et al., 2003).  
To bridge the gap of missing kinase mechanism in the model proposed by 
Nash et al., we performed a detailed study of the multisite phosphorylation 
dynamics and specificity of Sic1 by different cyclin-Cdk complexes. By using a 
noninhibitory version of Sic1 (the KID at positions 215–284 was deleted, 
designated Sic1ΔC) encompassing all of its optimal Cdk1 sites, we first 
demonstrated that both Cln2-Cdk1 and Clb5-Cdk1 were phosphorylating Sic1 
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processively. It appeared that the processivity of the Cdk holoenzyme complex 
was simultaneously mediated by Cks1 and the cyclin subunits (Ref. II: Fig. 1, 
Fig. 2 and 3, Supplementary Fig. 1, 2 and 4; Ref. IV; Fig. 1, Fig. 2, Supplemen-
tary Fig. 1). 
Including the Cks1 subunit in purified preparations of cyclin-Cdk1 the 
hyperphosphorylated forms of Sic1 appeared without notable accumulation of 
the intermediate phosphoforms (Ref. II, Fig. 1 and Supplementary Fig. 1). Most 
importantly, we demonstrated that Cks1 mediated priming had its own determi-
nants of specificity. The distance between the priming site and the target site is 
important. Cks1 mediated Cdk activity to its target sites over a sharp optimum 
peak at a distance 12–16 amino acids from the priming site. Priming by Cks1 
was unidirectional, working from the N-terminus to the C-terminus (Ref. IV, 
Fig. 3, Supplementary Fig. 3 and 8, Supplementary Table 1, Fig. 4). Moreover, 
Cks1 binding has its own consensus requirements. Cks1 only binds phosphory-
lated threonine followed by proline and discriminates phosphoserine residues in 
that context (Ref. IV, Fig. 2, Supplementary Fig. 1) (McGrath, et al., 2013). 
Additionally, specific proline residues in position (–2) enabled better Cks1 
docking and widened the effective distance to 18–25 amino acids (Ref. IV: Fig. 
3, Fig. 4, Supplementary Fig. 3 and Supplementary Table 1). 
The processive phosphorylation manner is enhanced by cyclin-specific 
docking sites. The processivity of Clb5 is dependent on the R/KXL motifs of 
the substrate (Ref. II, Fig. 2, Fig. 3), and the processivity of Cln2 is dependent 
on the VLLPP motif of the substrate (Ref. II, Fig. 3, Supplementary Fig. 4). 
Similar to Cks1, cyclin subunit-mediated docking had an optimal distance for 
enhancing Cdk1 activity. For hydrophobic patch docking, the optimal distance 
was 16–20 amino acids between the R/KXL motif and the target phosphory-
lation site (Ref. IV, Fig. 5). B-type cyclins enhance docking in a strictly uni-
directional manner but reciprocal to that of Cks1, that is, from the  
C-terminus to the N-terminus (Ref. IV, Fig. 5). However, Cln2 docking 
enhanced phosphorylation in both directions (Ref. IV, Fig. 5). Substrate recruit-
ment by Cln2 is assisted by abundant and not very specific hydrophobic 
contacts over the Sic1 molecule and therefore has more plasticity. 
The specificity requirements of different cyclin-Cdk complexes all manifest 
in Sic1 phosphorylation. We demonstrated that through the VLLPP motif, Cln2 
effectively primed the Sic1 T5 and T33 sites and much less effectively primed 
the T45, S76, T173 and S191 sites (Fig. 7). The phosphorylation of the latter 
sites is only improved if the N-terminal T5 or T33 are already phosphorylated. 
Moreover, Cln2-Cdk1-Cks1 is rather inefficient in phosphorylating the T48, 
S69 or S80 sites (Ref. II, Fig. 2), the sites that form double degrons of Sic1 
(Fig. 7). In contrast, the Clb5-Cdk1-Cdk1 holoenzyme used priming avidly 
from the T5 to the T33 sites to mediate the phosphorylation of the T45, S69, 
S76 and S80 sites (Ref. II, Fig. 2; Ref. IV: Fig. 2, Supplementary Fig. 2). 
Additionally, Clb5 was able to prime T5 and T33 by using the 2nd and 3rd 
R/KXL motifs of Sic1 (Fig. 7). For targeting S76 and S80, Clb5 exclusively 
used the 3rd R/KXL motif (Ref. II, Fig. 2). Additionally, phosphorylated T45 
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improved the targeting of the S69 and S80 sites by the Cln2-Cdk1-Cks1 
holoenzyme (Ref. IV, Fig. 6). 
 
Figure 7. Processive or semiprocessive pathways of Cln2 and Clb5 in Sic1. The 
ribbon diagram of Sic1 is separated into different modules. Most N-terminal is 
phosphopriming module (greenish blue). A module containing the phosphorylation sites 
necessary for Sic1 degradation follows this (light blue). In the central part of Sic1 the 
RXL and VLLPP sites form cyclin docking module (blue). Most C-terminal part 
contains KID that forms inhibitory module for Clb5,6-Cdk1. Phosphorylation sites are 
marked with circles, cyclin docking sites with rectangular boxes. G1-specific cyclin-
Cdk1 (Cln2) is able to provide priming (blue lines originating from red box “G1-CDK”) 
by using cyclin-docking module (blue lines entering red box “G1-CDK”). Cln2 is able 
to progress in N-to-C terminal direction by using generated priming phosphorylation to 
target a subset of phosphorylation sites in Sic1, excluding the last degradation output 
sites in degron module. Clb5-Cdk1 (beige, “S-CDK”) is inhibited by KID module. If in 
excess it phosphorylates Sic1 N-terminal modules by benefiting from the cyclin docking 
module (blue lines entering the box “S-CDK”). Clb5-Cdk1-Cks1 complex processively 
phosphorylates all degron module sites by using priming and docking module. 
 
The T45, S76, S80 sites, and more importantly the nonoptimal site T48, are 
responsible for high-affinity interactions between Sic1 and Cdc4, thus gene-
rating Sic1 degradation (Hao, et al., 2007). We demonstrated in vivo that both 
degron pairs T45/T48 and S76/S80 contributed to Sic1 degradation and that the 
T45/T48 degron pair was indispensable (Ref. II, Fig. 2, Supplementary Fig. 2 
and Fig. 4). As our results demonstrated, access to these sites was different 
between the Cln2- and Clb5-mediated Cdk1 (Fig. 7). The priming resulting 
from the T33/T45 sites and the R/KXL motifs were crucial for the rescue from 
cell-cycle arrest in the Sic1 overexpression system (Ref. II, Fig. 2 and 4), 
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further corroborated this by inhibiting Clb5-Cdk1-specific activity by using the 
KID of Sic1 expressed from an exogenous source and monitored the behavior of 
Sic1-wt expressed from an endogenous source. If Clb5-Cdk1 activity was 
completely inhibited, the endogenous Sic1-wt was stabilized (Ref. II, Fig. 3). 
Our results explain why T48 was reported to be missing from most of the 
previous in vitro studies if the main phosphorylation driver was Cln2-Cdk1 
without the Cks1 subunit (Nash, et al., 2001). In the Cln1-3 shutdown yeast 
strain arrested in G1, Verma et al. were unable to recover sufficient amounts of 
detectable Sic1 phospho-T48 or phospho-S76 peptides, although they were able 
to recover all six optimal Cdk-consensus motif-containing phosphopeptides 
(Verma, et al., 1997). 
Our study presents a new model for Sic1 phosphorylation and G1/S 
transition in budding yeast (Fig. 8). We found that Sic1 degradation output was 
exclusively generated by Clb5-Cdk1 whereas Cln2-Cdk1 activity served as a 
priming event. The Sic1 N-terminal pathway was phosphorylated in a proces-
sive or semiprocessive manner by using dual docking via Cks1 and a cyclin 
subunit (Fig. 7). All the components have their own output specificities and 
tunable ranges of Cdk1 activation. The assembly of such components in the 




Figure 8. A model diagram of the improved G1/S switch including a positive 
feedback component. Left: Sic1 (blue box) stoichiometrically inhibits S-Cdk1 (beige 
box) but do not inhibit G1-CDK (red box). Through semiprocessive phosphorylation 
(blue arrows from left to right), Sic1 is primed by G1-Cdk1 (arrow originating from red 
box). Primed Sic1 (red circles) is further phosphorylated by S-Cdk if latter is exceeding 
Sic1 concentration (beige arrow). This phosphorylation step finishes Sic1 
phosphorylation pathway by S-Cdk triggering Cdc4-dependent degradation of Sic1 
(light pink complex at right side). Note that S-Cdk phosphorylation step generates 











5.3. Abruptness of the G1/S switch is generated by 
feedback loops between Sic1 and the Clb5-Cdk1-Cks1 
holoenzyme (Ref. III) 
Our new model of Sic1 degradation at the G1/S transition (Fig. 8) presented in 
Ref. II proposes a double-negative feedback loop between Sic1 and S-Cdk with 
G1-Cdk assuming the role of a priming kinase and a trigger. This is in stark 
contrast to the previous model by Nash et al that proposes an ultrasensitive 
response to Sic1 degradation likely resulting from the allovalency of Cdc4 
binding, which in turn is a response to the G1-Cdk signal. We aimed to create a 
quantitative framework for the new G1/S model using mathematical modeling 
and numerical simulation of ordinary differential equations (ODE) systems. 
Sic1 degradation and release of Cdk1 activity in S phase is followed by a 
bistable switch-like response (Cross, et al., 2002). In the case of multisite subst-
rates, a high degree of processivity might lose ultrasensitive behavior and there-
fore bistability (Takahashi, et al., 2010; Salazar & Höfer, 2009). The bistable 
nature of the input-output conversion in processive systems can be restored by 
adding a feedback loop (Salazar & Höfer, 2009). Moreover, highly switch-like 
bistable behavior is achievable with systems combining distributive and 
processive mechanisms with a feedback loop (Salazar & Höfer, 2009). 
First, we performed a quantitative Sic1 dose response analysis for the Clb5-
Cdk1-Cks1 and Cln2-Cdk1-Cks1 complexes (Ref. III, Fig. 1). The calculated 
IC50 for the Clb5 holoenzyme is approximately 1 nM whereas the Cln2 
holoenzyme is not inhibited (Ref. III, Fig. 1). Therefore, we proposed that the 
Sic1 off-rate from the Clb5-Cdk1-Cks1 complex was extremely low. The 
stoichiometric inhibition was an important feature in generating bistability, as 
we saw later in this study.  
We further tested whether the extracomplex phosphorylation rates toward 
Sic1 engaged in the inhibitory complex of Clb5-Cdk1-Cks1 were similar to the 
noninhibitory Sic used in Ref. I – III. By titrating the Clb5 holoenzyme con-
centration over the concentration of the inhibitory Sic1, the results indicated that 
Sic1 binding to the Cdk1 complex did not affect its substrate qualities for 
extracomplex phosphorylation (Ref. III, Fig. 2). As expected, the Clb5 
holoenzyme was processing both the complexed and noninhibitory Sic1 with 
higher rates than was Cln2 (Ref. III, Fig. 2). Simultaneously, the phosphory-
lation rates between the full length Sic1 and Sic1ΔC were similar except that 
Clb5-Cdk1 had slightly higher rates toward the complexed Sic1 (Ref. III, 
Fig. 3). This result demonstrated that the Sic1 N-terminal region, although 
complexed with the Clb5 holoenzyme, was freely accessible for outer enzyme 
activity, which is also in agreement with the results obtained by assaying Cdc4 
binding and ubiquitination in vitro (Verma, et al., 1997). Therefore, during the 
G1/S transition, the initial release of the Clb5-Cdk1-Cks1 complex could further 
accelerate Sic1 degradation and its own release and generate a double-negative 
feedback loop for Sic1 destruction (Fig. 8). 
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We generated an ODE model to simulate the concentrations of free Sic1, 
free Clb5 and complexed Sic1-Clb5-Cdk1 in the G1/S transition (Fig. 9). Our 
model contains three ODE equations (Ref. III, Table 1). First equation describes 
free Sic1 levels, second describes free Clb5 levels and third equation describes 
the concertation of Sic1-Clb5-Cdk1 inhibitory complex. The concentrations of 
free Sic1 and Sic1-Clb5-Cdk1 complex were set to depend on the complex for-
mation Kd (or principally IC50 in this case) and Cln2 basal degradation activity 
toward complexed Sic1. The concentration of free Clb5 was dependent on the 
complex Kd and the sum of the destruction rates of the complexed Sic1 (two 
rates: Cln2 basal, Clb5 outer). The observed processivity in Ref. I – III enabled 
us to simplify the model by excluding phosphorylation intermediates. The 
phosphatase rate was summarized in the net phosphorylation rate, and the 
degradation of Sic1 was considered a nonlimiting step. 
As expected, in the case of tight inhibition and positive feedback generated 
by fast extracomplex Clb5 activity, the emergence of free Clb5 followed a steep 
hysteretic curve with a robust bistable property, where one stable state corres-
ponded to high Sic1 and low free Clb5 and the other to high free Clb5 and low 
Sic1 (Fig. 9; Ref. III, Fig. 4). Importantly, the steepness of hysteresis was 
dependent on the IC50 value of the inhibitory complex (Ref. III, Fig. 5). 
Increasing the IC50 to 100 nM caused the hysteretic behavior and bistability of 
the system to be lost (Ref. III, Fig. 5). Therefore, only the low nanomolar Ki 
values were required to inhibit Clb5 activity during its accumulation and 
subsequent release during the G1/S transition (Fig. 9). 
Moreover, the hysteretic behavior of Clb5 release was dependent on the 
limited activity of Cln2 towards the Sic1 degron output sites (Ref. III, Fig. 6–8). 
When increasing Cln2 activity from 0,01 to 0,3 fraction units of Clb5 activity, 
the hysteresis and sufficient Sic1 threshold levels were lost, resulting in the loss 
of bistability (Ref. III, Fig. 6–8). Strikingly, this model presented an option to 
tune the fractional Cln2 activity between 0,01 and 0,1 units without a significant 
loss in hysteresis but with the ability to shift the timing of when the G1/S 
transition occurred. Therefore, weak Cln2 activities toward Sic1 degradation 
might be important for controlling and fine-tuning the timing of the G1/S 
transition.  
Another important property revealed is that by tuning Cln2 extracomplex 
activity, it is possible to prime Sic1 for emerging free Clb5, which in turn would 
enable to fine-tune the Sic1 threshold levels for emerging free Clb5 before the 
G1/S takes place. This behavior suggests the AND gate type decision process 
where sufficient activities of both G1 and S phase cyclins must be present to 
trigger the switch. Omitting Cln2 from the model resulted in a delayed but less 




Figure 9. Simulation of the G1/S transition by the ODE model. The ODE system 
describes three variables: free Sic1 levels (red line), free Clb5 levels (greenish-blue line) 
and levels of Sic1-Clb5-Cdk1 inhibitory complex (blue line). Total Clb5 and Cln2 
levels are set to accumulate by constant rates (pink and beige lines respectively) and 
initial total Sic1 levels are set steady (pink line). The ODE is defining three main 
variables by using the phosphorylation rates of Cln2 and Clb5-Cdk1 and Kd of Sic1-
Clb5-Cdk1 inhibitory complex. The bistability of the switch is dependent on abrupt Sic1 
degradation, which in turn is dependent on a positive feedback mechanism generated by 
Clb5-Cdk1 activity (upper panel). The abruptness is lost if rising Cln2-Cdk1 levels are 
able to degrade Sic1 with comparable rates to Clb5 itself (center panel). A similar 




















































































Our results were independently corroborated by an elegant single-cell study 
observing the in vivo dynamics of Sic1 during the G1/S transition by the Tang 
group (Yang, et al., 2013). First, they demonstrated that Clb5,6, and not Cln1,2, 
are primarily responsible for the degradation profile of Sic1. Second, Cln1,2 
affects the variability and median of Sic1 degradation timing from Whi5 nuclear 
exit (defined as START) and does not affect the Sic1 degradation half-time 
(Yang, et al., 2013). They concluded that the abruptness of the G1/S transition 
is generated by a double-negative feedback loop provided by Clb5 itself and 
that the robust timing is maintained by Cln1,2 via Sic1 priming (Yang, et al., 
2013). In addition, the presence of Clb5,6 is crucial to dampening the noise 
generated by environmental perturbations that affect G1 cyclin expression 
levels, which under Clb5,6 deletion generate a large variability in the Sic1 half-
life (Yang, et al., 2013). The ODE presented by them proposes that the feedback 
loop, and not the multisite option, is responsible for the abruptness of the G1/S 
switch (Yang, et al., 2013). The limited activity of the primer kinase functions 
as a timer of the switch (Yang, et al., 2013). The bistability is a result achieved 
through double-negative feedback (Yang, et al., 2013). 
The conclusion of our study is that the G1-Cdk priming model combined 
with the S-Cdk double-negative feedback system proposed by us and Tang is 
kinetically possible. Our study found that the key parameter for ensuring 
ultrasensitivity is the stoichiometric inhibition of S-Cdk by Sic1, limited 
degradation activity of G1-Cdk1 and a positive feedback loop provided by  
S-Cdks. Differentiated tasks of G1 and S-type cyclin Cdk activities enable fine-
tuning and the sharpness of the G1/S switch and provides filtering mechanisms 
to dampen the effects of noise. It is likely that evolutionarily fine-tuning 
biological systems uses simultaneously mixed but highly balanced mechanisms 
that include distributive, processive and feedback components. 
 
 
5.4. Intracomplex phosphorylation step process input 
signals (Ref. V) 
We outlined a new model for Sic1 degradation and G1/S transition in budding 
yeast (Fig. 8). Here, we address a still unsolved question of how S-Cdk, while 
being inhibited by Sic1, could at the same time, be the major driving force in 
Sic1 phosphorylation and degradation. We observed that, despite the tight 
nanomolar inhibition of S-Cdk by Sic1, Sic1 was still phosphorylated within the 
inhibitory complex. Our hypothesis was that intramolecular phosphorylation 
provides an intermediate step between Sic1 priming by G1-Cdk and the final 
abrupt destruction by release of S-Cdk. 
This idea was partly derived from studies on mammalian Cki p27 where the 
priming phosphorylation releases an intramolecular phosphorylation activity of 
otherwise inhibited cyclin-Cdk complexes, providing an intermediate step of 
Cdk activity before the abrupt G1/S transition. The silent ternary G1 and S-type 
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cyclin-Cdk complexes are awakened by regulated unfolding which includes 
multistep phosphorylation of the KID of p27 (Grimmler, et al., 2007; Ou, et al., 
2011; Ou, et al., 2012). The priming step is generated by promitogenic tyrosine 
kinases that sequentially target specific residues of p27 KID, which in turn 
triggers the initial low rate of Cdk activity (Ou, et al., 2012). The low rate of 
Cdk activity leads to the intracomplex phosphorylation of the flexible CTD tail 
to phosphorylate T187 of p27 (Grimmler, et al., 2007; Galea, et al., 2008). This 
step initiates ubiquitin-dependent degradation of p27 and the release of the 
active cyclin-Cdk complex (Montagnoli, et al., 1999). 
 
 
5.4.1. The extent of intracomplex phosphorylation is reciprocally 
dependent on the status of Sic1 T5 and T173 
We observed that during the formation of the Sic1-Clb5-Cdk1-Cks1 inhibitory 
complex, limited, rapid, intramolecular phosphorylation independent of the 
Clb5:Sic1 ratio if Sic1 was taken in excess occurred (Ref. V, Fig. 1d,e, Supple-
mentary Fig. 1c). 
Surprisingly, some fraction of Sic1 was highly hyperphosphorylated to con-
tain 8–10 phosphates per Sic1 molecule, which in vivo could lead to its destruc-
tion (Ref. V, Fig. 1e and 2a). The abundance of the hyperphosphorylated form 
appears to be dependent on the Cdk1 subunit Cks1 and the Sic1 N-terminal T5 
and C-terminal T173 sites (Ref. V, Fig. 2a, Supplementary Fig. 1d). In the case 
of the Sic1 T173A or T173S sites, extensive accumulation of the hyper-
phosphorylated forms of the complexed Sic1 were observed in vitro (Ref. V, 
Fig. 2a,b; Supplementary Fig. 1d,f). In the case of the Sic1-wt, an average level 
of hyperphosphorylation of Sic1 was observed. In the case of the T5 mutants, 
the extent of the hyperphosphorylation was reduced (Ref. V, Fig. 2a,b; Supple-
mentary Fig. 2f). 
The intramolecular phosphorylation process is entirely dependent on the 
Sic1 KID and Cks1. If the KID is removed (Sic1∆C), the phosphorylation 
dynamic between Sic1-wt and Sic1-T173A is indistinguishable, demonstrating 
that only the intramolecular phosphorylation step could generate differences in 
Sic1 phosphorylation patterns for the T173 site (Ref. V, Supplementary 
Fig. 1g). Cks1 removal leads to uncontrollable accumulation of the hyper-
phosphorylated forms, similar to Sic1 T173S or Sic1 with all the Cdk sites 
mutated to serine residues (Ref. V, Fig. 2a,b, Supplementary Fig. 1f). 
Our previous studies have identified T5 and T33 as priming sites for the  
N-terminal degradation pathway, whereas phosphorylation of T173 was pre-
viously shown to generate a G1/S delay (Zinzalla, et al., 2007; Escoté, et al., 
2004; Moreno-Torres, et al., 2015). Additionally, phosphorylated T173 was 
proposed to turn Sic1 from substrate to inhibitor for Clb5-Cdk1 by using its 
phospho-adaptor subunit Cks1 (Moreno-Torres, et al., 2017). However, the Sic1 
T173A, Sic1 T173S or Sic1 with all the Cdk sites mutated to alanine residues 
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had no variations in their IC50 values for inhibiting Clb5-Cdk1-Cks1 activity 
against the external substrate H1 compared with the Sic1-wt (data not shown). 
Therefore, we hypothesized that T5 and T173 might serve as reciprocal 
regulators setting limits to the extent of hyperphosphorylation of Sic1 by Clb5-
Cdk1-Cks1 intramolecular process. 
 
 
5.4.2. Intramolecular process regulates Sic1 threshold levels  
in vivo in response to Fus3 and Cln2 activity 
We discovered that in addition to previously identified input kinases, phero-
mone-activated kinase Fus3 was targeting Sic1 T173 in vivo and in vitro 
(Ref. V, Supplementary Fig. 2b,d,f). Surprisingly, Fus3 also phosphorylated 
T45 in vitro (Ref. V, Supplementary Fig. 2d). Most importantly, the addition of 
Fus3 enabled us to observe the effect of T173 phosphorylation on the dynamics 
of Sic1 vivo by using a mating pheromone and single-cell fluorescence micro-
scopy (Ref. V, Fig. 3). If the cells were treated with a short high-concentration 
(240 nM) pheromone pulse followed by a flow of low-concentration (3 nM) 
(Ref. V, Fig. 3a), the exit of Whi5 was delayed and G1 was prolonged (Doncic 
& Skotheim, 2013; Doncic, et al., 2015). Simultaneously, Clb5 was 
accumulating (Ref. V, Fig. 3f) opening up the possibility of testing the effects 
of Fus3 on Clb5 intramolecular priming in vivo.  
Strikingly, under these conditions, the phosphorylation status of T173 was 
decisive. The Sic1 T173A or T173S site was degraded 40 minutes earlier 
(Ref. V, Fig. 3d,c,e,h, Supplementary Fig. 3a,b) than the Sic1-wt was (Ref. V, 
Fig. 3d,b,e,g), and that is far earlier than the Whi5 nuclear exit (Ref. V, Fig. 3h). 
Sic1 with all the N-terminal Cdk sites mutated to serine residues (Sic1-9SP) 
rescued the phenotype of early degradation (Ref. V, Fig. 3e,i). Therefore, early 
Sic1 degradation most likely occurs due to intramolecular turnover by Clb5-
Cdk1 dependent on Cks1. Moreover, to cause such an effect, the previous input 
signal to Sic1 T173 must have been present, because in asynchronously 
dividing cells no differences in dynamics between full length Sic1-wt and Sic1-
T173S were observed (data not shown). Asynchronously growing cultures of 
cells lack the pheromone (or other stressor) input to Sic1, and therefore, they 
progress quickly to the G1/S switch. For cells to sense the status T173 
phosphorylation, the KID was crucial. The deletion of the KID (Sic1∆C) caused 
all differences between Sic1-wt and Sic1-T173S in vivo to be lost (Ref. V, 
Supplementary Fig. 3c), confirming that only the intracomplex phosphorylation 
step is sensitive to the status of the T173 site. 
Most importantly, the N-terminal (T5) and C-terminal (T173) input sites 
regulated Sic1 levels via intramolecular phosphorylation by Clb5-Cdk1-Cks1. If 
the N-terminal input T5 or VLLPP motif was mutated, the Sic1 level in 
prolonged G1 arrest was elevated (Ref. V, Fig. 3j, Supplementary Fig. 3d). This 
result demonstrates that Cln1-3 was responsible for generating a signal affecting 
the Sic1 threshold in prolonged G1. We further attempted to influence the Sic1 
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levels by connecting Cln2 to the T173 site by optimizing the T173 site to be 
Cln2-Cdk1-specific (–2P+2K+3A). As expected, this resulted in elevated Sic1 
levels in G1 arrest, suggesting an elevated T173 input (Ref. V, Fig. 3k). In 
addition, we altered the N-terminal to C-terminal priming balance by upgrading 
the N-terminal pathway with three additional Cdk sites and a potential double-
site degron to compete with T173 phosphorylation and, as expected, this 
resulted in a lowered Sic1 level (Ref. V, Fig. 5a). 
In addition, we were curious about whether Clb5 affected Sic1 levels through 
the N-terminal 2nd and 3rd RXL motifs. Our previous results suggested that 
mutating the RXL motifs would not affect the Sic1 levels because first, no 
extramolecular Clb5 process would be present due to high affinity binding to 
Sic1 and second, the intramolecular process would be independent of the cyclin 
hydrophobic patch that was likely already occupied by the KID. Unexpectedly, 
the RXL mutations caused the Sic1 level to drop (Ref. V, Fig. 3k). Mutations in 
the RXL motifs did not cause considerable effects to the intramolecular 
phosphorylation patterns in vitro (Ref. V, Supplementary Fig. 1f). This finding 
confirms that the intramolecular process itself was not responsible for the effect. 
We found that Fus3 was dependent on the docking site overlapping with the 2nd 
RXL motif and that this affected T173 phosphorylation by Fus3 (Ref. V, 
Supplementary Fig. 3e). Moreover, the docking site identified did not affect the 
Fus3 phosphorylation rate toward T45 (Ref. V, Supplementary Fig. 3e), which 
is a component of the Sic1 T45/T48 degron and serves as priming site of Cln2 
for S76/S80 degron. Therefore, it is likely that Fus3 generated a dual input 
signal for Sic1, one for diversions and one for degradation. If the diversional 
signal was reduced by altering the docking site, the input balance would shift 
toward the degradation signal and the Sic1 levels would drop. 
Therefore, we have demonstrated that T5 and T173 create a priming balance 
that is processed via the Clb5-Cdk1-Cks1 intramolecular phosphorylation 
mechanism into steady-state threshold levels of the G1/S inhibitor. 
 
 
5.4.3. G1/S timing is dependent on the Clb5-Cdk1-Cks1  
intramolecular process 
Upon the Whi5 nuclear exit (START), which marks the shutdown of the Fus3 
signal (Oehlen & Cross, 1994; Strickfaden, et al., 2007; Repetto, et al., 2018), 
the situation of input signals changes. Our data revealed that after Fus3 activity 
was discontinued the rising Cln2 levels took over and kept the Sic1 levels 
steady. 
Together with Clb5 the Cln2 levels began an accelerated accumulation after 
START whereas the Sic1-wt protein levels stayed steady (Ref. V, Fig. 3f,g). 
Strikingly, the Sic1 levels started to increase when the Cln1, 2 input sites were 
mutated (Ref. V, Fig. 3j, Supplementary Fig. 3d). In this case, the growth rate in 
Cln1-3 activity was unable to compensate for the loss of Fus3 activity toward 
the Sic1 T45 site and, therefore, unable to compensate for the accumulation rate 
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of Sic1. According to previous results presented by the Tang group (Yang, et 
al., 2013) the altered Cln1-3 input in Sic1 affects the timing of the Whi5 exit but 
does not affect the degradation half-time during the G1/S transition once the 
external Clb5 double-negative feedback is activated. According to the Tang 
group (Yang, et al., 2013), the Cln2 input is unimportant if the double-negative 
feedback loop of free Clb5-Cdk1 is not activated. 
In case of defective Cln2 input sites, the delay in the G1/S switch was 
detected only in full-length Sic1 (Ref. V, Fig 4a,b, Supplementary Fig. 3d). This 
result suggests that the lack of Cln2 priming was important only if the inhibitory 
threshold was determined via following the intramolecular phosphorylation 
process and is relatively unimportant if no additional intramolecular process is 
followed in the case of KID truncation. In the case of defective Cln2 input, to 
reach the G1/S transition, ever-higher Clb5 accumulation rates were necessary. 
The truncation of the KID in Sic1-wt generated a 4 minutes delay in the G1/S 
transition (Ref. V, Fig. 4a,b). This observation suggests that although Sic1-wt 
with a truncated KID contains a fully available Cln2 input, it lacks an intra-
molecular step and therefore has to wait for higher amounts of free Clb5 to 
achieve abrupt degradation of Sic1-wt. Therefore, Cln2 priming is important to 
the intracomplex phosphorylation mechanism. 
The Clb5-Cdk1 double-negative feedback loop is dependent in RXL motifs. 
Mutations in these motifs affected timing of both the full length and truncated 
Sic1 (Ref. V, Fig. 4a,b). In the case of KID truncation, the effect in timing was 
more pronounced. This effect can be explained by omitting the intracomplex 
step that resulted in limited phosphopriming and that caused additional effect in 
timing. It appears that the extra complex Clb5 is highly dependent on RXL 
docking but is also fine-tuned by an intracomplex priming step to initiate a 
double-negative feedback loop. 
In this study, we resolved the missing connection between single-site input 
and double-negative feedback phosphorylation events. The processor appears to 
be Clb5-Cdk1-Cks1 itself, its intramolecular phosphorylation mode, which is 
able to turn the multisite phosphorylation option of Sic1 into a relay that fine-
tunes the initiation of its own double-negative feedback loop. Previously, the 
T173 site was identified as an input of starvation related signals from the target 
of rapamycin complex 1 (TORC1) pathway and phosphorylation of the site 
caused Sic1 stabilization (Zinzalla, et al., 2007; Moreno-Torres, et al., 2015; 
Moreno-Torres, et al., 2017). Our study demonstrates that the stress signal via 
the Sic1 T173 site is processed only if the Clb5-Cdk1-Cks1 intracomplex 




The core elements of the S. cerevisiae cell cycle control mechanism have been 
known for more than two decades. The past decade has focused on dynamic 
relationships between these elements to unveil quantitative mechanisms of cell 
cycle regulation. Our present study began with the quantitative characterization 
of different cyclin-Cdk activities. From simple active site specificities, we 
quickly moved on to characterize docking effects and to quantitatively measure 
substrate phosphorylation dynamics in a multiphosphorylated system. This 
investigation led us to unveil the elements of signal processing in G1 and the 
G1/S transition related to the cell cycle inhibitor Sic1 and the regulatory cyclin-
Cdks. We identified three different Cdk activity modes in Sic1 phosphorylation: 
a priming step (Ref. I), an intracomplex phosphorylation step (Ref. V) and an 
extracomplex double-negative feedback (Ref. II–IV). The resulting modified 
G1/S model enabled us to assess the dynamic relationship between different 
input signals and properties of the switch. The results of this study are listed 
below. 
1. We identified the specificity determinants at the level of the primary 
structure of the substrate for the Cdk1 active site associated with different 
cyclins and quantitatively characterized the effect of these determinants on 
cyclin-Cdk activity. 
2. We identified docking requirements for the processive multistep phosphory-
lation mechanism for different cyclin-Cdk complexes and quantitatively 
characterized the effect of these determinants on cyclin-Cdk distributive and 
processive activities. More specifically, we characterized the effect of the 
Cks1 phospho-adaptor subunit (for phosphorylated threonines) and the 
cyclin hydrophobic docking sites (for RXL and VLLLPP motifs) and identi-
fied optimal distances in the multiphosphorylating network of the Sic1 
protein. 
3. We demonstrated the double-negative feedback loop to trigger the G1/S 
transition.  
4. We resolved the multisite phosphorylation pathway of Sic1 into different 
modules responsible for different tasks, i.e., priming sites, specific output 
sites and a diversional module of T173.  
5. We quantitatively assessed the effect of each module in connection with Cdk 
activity and the G1/S transition. 
6. We successfully used the elements of the Sic1 pathways to remodulate the 
signal processing properties. 
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SUMMARY IN ESTONIAN 
Kõikide päristuumsete elusorganismide rakkude jagunemise tsüklit saab jagada 
kaheks etapiks: interfaasiks ja mitoosiks (M-faasiks). Selline jaotus tekkis 19. 
sajandi keskel ajal, mil rakkude jagunemist uuriti peamiselt kasutades algelist 
valgusmikroskoopi. Interfaasis rakk kasvab või lihtsalt elutseb, mitoosis aga 
jagab organellid, tuuma ja tsütoplasma kaheks, lõpetades kahe eraldiseisva 
tütarrakuna. 
Alles 1950.ndate aastate alguses, mil rakubioloogia jõudis tõeliselt moleku-
laarse tasandini, märgati, et interfaasi käigus toimub raku pärilikkusaine (DNA) 
kahekordistamine. Aega interfaasis, mis kulub DNA kahekordistamisele, hakati 
edaspidi nimetama S-faasiks. Lisaks märgati, et S-faasi ja sellele järgneva 
mitoosi vahel on ajaline paus. Seda hakati nimetama G2 faasiks. S faasile eelne-
vat aega, kus rakud kasvavad, hakati nimetama G1 faasiks. Sellega eristusid 
raku jagunemistsüklis järjestikku paiknevad G1, S, G2 ja M faas. 
1970.ndatel aastatel tehti kindlaks, et raku jagunemise tsüklit iseloomustab 
alati ühesuunalisus ning täielik pöördumatus. Nii ei ole peale S faasi sisenemist 
enam võimalik eelmisesse, see on G1 faasi, tagasi pöörduda. Samuti ei ole või-
malik pöörduda peale M-faasiga alguse tegemist enam tagasi eelmise, G2 faasi, 
tegevuste juurde. Neid momente raku jagunemise etappide vahel, kus on justkui 
seatud ette vaid ühte pidi läbitav vahesein, nimetatakse raku jagunemise 
kontrollpunktideks. 
1980.ndatel aastatel, seoses geenitehnoloogiliste meetodite jõudsa arenguga, 
hakati iseloomustama raku jagunemise tsüklit mõjutavate geenide produkte. 
Geenid ise olid suures osas 1970.ndatel aastatel juba kaardistatud süstemaati-
liste mutatsioonide abil, kasutades mudelorganismina pärmseeni. 
Peamiste regulaatoritena avastati tsükliinidest sõltuvad kinaasid. Need on 
valgud, mis lisavad teistele valkudele fosfaatseid jääke, mis toimivad signaal-
märgistena sihtmärkvalgu saatuse määramisel. Ka kinaasid ja neid aktiveerivad 
tsükliinid on valgud. Fosforüleerimise teel muudavad need sihtmärkvalkude 
aktiivsust, suunavad nende paigutamist rakus või määravad need lagundamisele. 
Rakutsüklit reguleerivate kinaaside aktiivsus on määratud eelkõige tsükliinide 
poolt, mis annavad kinaasi osaühikule töövõime ja määravad ka tema siht-
märkide eelistused. Tsükliinid on rakutsüklis väga rangelt reguleeritud – nad 
tekivad täpselt siis, kui nende aktiivsust on tarvis ja nii kui nad on oma töö lõpe-
tanud, nad lagundatakse. Iga rakutsükli etapi jaoks on oma kindel või kindlad 
tsükliinid. Seejuures iga tsükliin käivitab endale järgneva tsükliini tootmise, mis 
on üks olulisi lisamehhanisme, kuidas on tagatud rakutsükli ühesuunaline 
kulgemine. Nende valkude tekkimise ja lagundamise perioodilisusest tuletati ka 
nende üldine nimetus – tsükliin. 
Lisaks tsükliinsõltuvatele kinaasidele avastati nende aktiivsust tugevasti 
pidurdavad valgud (inhibiitorid), mille roll on hoida kinaaside aktiivsust kont-
rolli all. Sarnaselt tsükliinidele töötavad ka inhibiitorid rangelt reguleeritud 
lainetena. Nii on pärmis S. cerevisiae G1 faasis tuvastatud inhibiitor Sic1. Selle 
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valgu peamiseks ülesandeks on lukustada S-faasi käivitava tsükliinsõltuva 
kinaasi aktiivsus ajal, kui seda tarvis ei lähe, ehk G1 faasi ajaks. Sellega aitab 
Sic1 rakkudel toota ja koguda S-faasi kinaasi piisaval hulgal ette, mis on 
vajalik, et hiljem tagada S-faasi veatu ja kiire läbiviimine. S-faas käivitatakse 
rakus plahvatusliku kinaasi aktiivsuse vabastamisega, mis on oluline selle 
tõrgeteta käivitamiseks. Plahvatusliku alguse tagab Sic1 lagundamise järsk 
dünaamika. Lisaks näitavad varasemad uuringud, et Sic1 on oluline S-faasi 
kinaasi vabastamise täpseks ajastamiseks, mis on oluline osa raku kaalutletud 
otsusest jagunema hakata. On oluline märkida, et samal ajal, kui Sic1 blokeerib 
S-faasi tsükliinsõltuva kinaasi aktiivsust, ei tee ta seda G1-faasi tsükliinsõltuva 
kinaasiga. 
Nagu märgitud, selleks et S-faasi käivitada, peab rakk vabanema inhibiitorist 
Sic1. See käib inhibiitorvalgu järsu lagundamise teel, mis omakorda on käivi-
tatud selle fosforüleerimisega. Sic1 valgule lisatakse järgemööda kokku kuni 10 
fosforhappe jääki. Fosforijääke lisavad rakutsüklit reguleerivad kinaasid, näi-
teks G1 kinaasid, mille aktiivsust Sic1 ei pidurda. Selleks, et käivitada Sic1 
lagundamine, on sellele vaja lisada mitu fosforhappe jääki. Varasemad uuringud 
on jäänud kahetisele seisukohale selles osas, kas Sic1 lagundamiseks tuleb 
lisada mingi piirarv fosfaate suvalistesse kohtadesse, või viib järgemööda 
toimuv fosfaatide lisamine Sic1 molekulil välja kindlatesse piirkondadesse, 
kuhu jõudmine käivitab lagundamise. Kuni viimase ajani ei olnud teada, kuidas 
täpselt nende paikadeni jõutakse, kas seda teeb G1-tsükliinsõltuv kinaas üksi 
või võtavad selle protsessi mingis etapis üle esmased vabanevad S-faasi kinaasi 
molekulid. Seetõttu ei olnud ka teada, mis tagab järsu plahvatusliku dünaamika 
Sic1 lagunemisel ning kuidas seda reguleeritakse nii, et rakutsükli S-faas ei 
käivituks liiga vara, ega ka mõttetult hilja. Seejuures on huvitav fenomen, et 
Sic1 on ühteaegu S-faasi kinaasile nii substraat kui ka inhibiitor, mis 
keemilisest loogikast lähtudes, on vastanduvad rollid. 
Käesoleva doktoritöö käigus mõõdeti G1 ja S-faasi tsükliinsõltuvate kinaaside 
erisusi Sic1 valgule fosforhappejääkide lisamisel. Meie töö tulemustena selgus, 
et G1 ja S-faasi tsükliinid mängivad väga erinevat, kuid omavahel täiesti seotud 
rolli Sic1 lagundamisel. Me leidsime, et Sic1 fosforüülimine on suunatud ning 
kindlas järjestuses toimuv protsess, mis tipneb lagundamiseks vajalike paikade 
fosforüülimisega. Eraldiseisvalt nendesse kindlatesse piirkondadesse fosfor-
happejääkide lisamine on väga vaevaline protsess, seda eriti G1 tsükliin-
sõltuvale kinaasile. Me avastasime, et Sic1 valgule fosforhappejääkide lisamine 
on kolmeastmeline protsess, mis koosneb rakutsükli G1 faasis toimuvast kahe-
astmelisest fosforüülimisest ning viimaks Sic1 lagundamisele suunavast fosfo-
rüülimisest G1/S üleminekul.  
Täpsemalt, G1 faasis toimub Sic1 osaline fosforüülimine mitteinhibeeritud 
kinaaside poolt. Seda kutsutakse ka praimerfosforüülimiseks. Siin fosforüülivad 
Sic1 valku mitmed kinaasid, mis tajuvad raku „tervislikku“ seisundit ning 
ümbritsevat keskkonda. Varasemalt on teada, et need kinaasid võivad raku 
jagunemist edasi lükata või ka varasemaks tuua, kuid seni puudus arusaam, 
kuidas nad seda teevad. Järgmises etapis tekivad S-faasi kinaasi kompleksid, 
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mis inhibeeritakse Sic1 poolt. Me avastasime, et inhibitoorse kompleksi 
moodustamise käigus fosforüülib inhibeeritav S-faasi kinaas Sic1 teatud 
tasemeni kuni viimane pidurdab kinaasi katalüütilise aktiivsuse täielikult. 
Lõpuks, olles jõudnud S-faasi käivitamiseks sobiva hetkeni, toimub Sic1 
viimase etapi fosforüülimine, mis viib tema lagundamiseni. Me avastasime, et 
viimane Sic1 fosforüülimise etapp sisaldab topelt-negatiivset tagasisidet vaba-
neva S-faasi kinaasi enda poolt, põhjustates G1/S lülituseks vajaliku aktiivsuse 
vabanemise plahvatusliku iseloomu. 
Erakordselt huvitavaks kujunes aga avastus, kuidas Sic1 kaudu regu-
leeritakse G1/S lülituse ajastamist. Nimelt, me leidsime, et esimese ja kolmanda 
etapi vahel toimuv inhibitoorse kompleksi sisene Sic1 fosforüülimine toimub 
mööda kahte erinevat rada. Üks rada suunab Sic1 lagundamiseks vajalike 
piirkondadeni, kuid teine rada viib tupikusse, kus Sic1 lagundamist ei järgne. S-
faasi kinaas, mille aktiivsust Sic1 pidurdab, ei oska ise kahe raja vahel valida, 
ning liigub kahe raja vahel juhuslikult. Samas, kui eelnevalt on tehtud praimer-
kinaaside poolt algust ühe või teise rajaga, valib S-faasi kinaas inhibitoorse 
kompleksi moodustumise käigus eelistatult selle raja. Mida rohkem on lagunda-
misele viivat rada ette märgitud, seda tõenäolisemalt valib ka S-faasi kinaas 
inhibiitoriga kompleksi moodustades oma jääk-aktiivsuse väljendamiseks selle 
raja ja seda raskem on Sic1 valgul S-faasi kinaasi aktiivsust pidurdada. Kui aga 
G1-faasis on ülekaalus kinaasid, mille sihtmärgiks on tupikraja alustamine, 
valib S-faasi kinaas selle raja ning jääb inhibitoorset kompleksi moodustades 
pidama tupikus. Selle mehhanismiga fikseeritakse eelseisvaks G1/S lülituseks 
Sic1 tase ning selle kaudu omakorda määratakse ette S-faasi alustamise aeg. 
Ühtlasi tagatakse, et stressiolukorras oleks võimalik hoida piisavat ajavaru 
olukorraga kohanemiseks. 
Sellega lahendasime me pärmi rakutsükli G1/S lülituse mudeli kvantita-
tiivsetel alustel. Oma viimases töös näitasime me õnnestunult, et tänu uudsele 
teadmisele on võimalik pärmi G1/S lülitust soovitud viisil ümber kujundada, 
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